UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)


☑			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September 30, 2022~~March 31, 2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-15169

PERFICIENT, INC.

(Exact name of registrant as specified in its charter)

Delaware

No.

74-2853258

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

555 Maryville University Drive

Suite 600

Saint Louis, Missouri 63141

(Address of principal executive offices)

(314) 529-3600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value	PRFT	The Nasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements during the past 90 days. þ Yes o No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). þ Yes o No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	þ	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ

As of ~~October 20, 2022,~~April 25, 2023, there were ~~34,628,444~~34,838,170 shares of Common Stock outstanding.

TABLE OF CONTENTS


Part I.	Financial Information	1

Item 1.	Financial Statements	2

	Condensed Consolidated Balance Sheets as of ~~September~~ ~~30, 2022~~March 31, 2023 (unaudited) and December 31, ~~2021~~2022	2

	Unaudited Condensed Consolidated Statements of Operations for the Three ~~and~~ ~~Nine~~Months Ended ~~September~~ ~~30,~~March 31, 2023 and 2022 ~~and 2021~~	3

	Unaudited Condensed Consolidated Statements of Comprehensive Income for the Three ~~and~~ ~~Nine~~Months Ended ~~September~~ ~~30,~~March 31, 2023 and 2022 ~~and 2021~~	4

	Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the Three ~~and~~ ~~Nine~~Months Ended ~~September~~ ~~30,~~March 31, 2023 and 2022 ~~and 2021~~	5

	Unaudited Condensed Consolidated Statements of Cash Flows for the ~~Nine~~Three Months Ended ~~September~~ ~~30,~~March 31, 2023 and 2022 ~~and 2021~~	76

	Notes to Interim Unaudited Condensed Consolidated Financial Statements	98

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3023

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	3627

Item 4.	Controls and Procedures	3728

Part II.	Other Information	3728

Item 1A.	Risk Factors	3728

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3728

Item 5.	Other Information	3829

Item 6.	Exhibits	3930

	Signatures	4031

PART I. FINANCIAL INFORMATION

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this Quarterly Report on this Form 10-Q (“Form 10-Q”) are not purely historical statements, discuss future expectations, contain projections of results of operations or financial condition, or state other forward-looking information. Those statements are subject to known and unknown risks, uncertainties, and other factors that could cause the actual results to differ materially from those contemplated by the statements. The “forward-looking” information is based on various factors and was derived using numerous assumptions. In some cases, you can identify these so-called forward-looking statements by words like “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of those words and other comparable words. You should be aware that those statements only reflect our predictions and are subject to risks and uncertainties. Actual events or results may differ substantially. Important factors that could cause our actual results to be materially different from the forward-looking statements include (but are not limited to) the ~~following, many of which are, or may be, amplified by the novel coronavirus (COVID-19) pandemic:~~following:

1.(1)the impact of the general economy and economic and political uncertainty on our business;

2.~~the impact of the COVID-19 pandemic on our business;~~

3.(2)risks associated with potential changes to ~~federal, state, local~~U.S. and foreign laws, regulations, and policies;

4.(3)risks associated with the operation of our business generally, including:

a.client demand for our services and solutions;

b.effectively competing in a highly competitive market;

c.risks from international operations including fluctuations in exchange rates;

d.adapting to changes in technologies and offerings;

e. the impact of the health emergencies and pandemics on our business which may amplify certain of the other factors contained herein;

f. obtaining favorable pricing to reflect services provided;

f.g. risk of loss of one or more significant software vendors;

g.h. maintaining a balance of our supply of skills and resources with client demand;

h.i. changes to immigration policies;

i.j. protecting our clients’ and our data and information;

j.k. changes to tax levels, audits, investigations, tax laws or their interpretation;

k.l. making appropriate estimates and assumptions in connection with preparing our consolidated financial statements; and

l.m. maintaining effective internal controls;

5.(4)risks associated with managing growth organically and through acquisitions;

6.(5)risks associated with servicing our debt, the potential impact on the value of our common stock from the conditional conversion features of our debt and the associated convertible note hedge transactions;

7.(6)legal liabilities, including intellectual property protection and infringement or the disclosure of personally identifiable information; and

8.(7)the risks detailed from time to time within our filings with the Securities and Exchange Commission (the “SEC”).

This discussion is not exhaustive, but is designed to highlight important factors that may impact our forward-looking statements. Because the factors referred to above, as well as the statements included under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2021,~~2022, including documents incorporated by reference therein and herein, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statement made by us or on our behalf, you should not place undue reliance on any forward-looking statements.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. We are under no duty to update any of the forward-looking statements after the date of this Form 10-Q to conform such statements to actual results.

All forward-looking statements, express or implied, included in this report and the documents we incorporate by reference that are attributable to Perficient, Inc. and its subsidiaries (collectively, “we,” “us,” “Perficient,” or the “Company”) are expressly qualified in their entirety by this cautionary statement. This cautionary statement should also be considered in connection with any subsequent written or oral forward-looking statements that the Company or any persons acting on our behalf may issue.

Item 1. Financial Statements

Perficient, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except share information)


		September 30, 2022 (unaudited)		December 31, 2021			March 31, 2023 (unaudited)		December 31, 2022
Assets	Assets					Assets
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	20,845	$	24,410	Cash and cash equivalents	$	40,995	$	30,130
Accounts receivable, net	Accounts receivable, net	192,903		177,602		Accounts receivable, net	183,455		202,298
Prepaid expenses	Prepaid expenses	6,536		5,400		Prepaid expenses	6,822		6,432
Other current assets	Other current assets	4,755		7,296		Other current assets	9,549		16,756
Total current assets	Total current assets	225,039		214,708		Total current assets	240,821		255,616
Property and equipment, net	Property and equipment, net	18,529		14,747		Property and equipment, net	16,785		17,970
Operating lease right-of-use assets	Operating lease right-of-use assets	29,357		33,353		Operating lease right-of-use assets	26,249		27,088
Goodwill	Goodwill	545,842		515,229		Goodwill	569,390		565,161
Intangible assets, net	Intangible assets, net	82,384		81,277		Intangible assets, net	83,746		88,937
Other non-current assets	Other non-current assets	47,586		23,258		Other non-current assets	44,864		41,116
Total assets	Total assets	$	948,737	$	882,572	Total assets	$	981,855	$	995,888

Liabilities and Stockholders’ Equity	Liabilities and Stockholders’ Equity					Liabilities and Stockholders’ Equity
Current liabilities:	Current liabilities:					Current liabilities:
Accounts payable	Accounts payable	$	19,300	$	26,074	Accounts payable	$	14,529	$	24,351
Other current liabilities	Other current liabilities	84,715		93,877		Other current liabilities	67,591		104,780
Total current liabilities	Total current liabilities	104,015		119,951		Total current liabilities	82,120		129,131
Long-term debt, net	Long-term debt, net	394,050		326,126		Long-term debt, net	395,159		394,587
Operating lease liabilities	Operating lease liabilities	20,661		23,898		Operating lease liabilities	20,313		18,528
Other non-current liabilities	Other non-current liabilities	45,741		47,832		Other non-current liabilities	46,084		43,515
Total liabilities	Total liabilities	$	564,467	$	517,807	Total liabilities	$	543,676	$	585,761
Stockholders’ equity:	Stockholders’ equity:					Stockholders’ equity:
Preferred stock (par value $0.001 per share; 8,000,000 authorized; no shares issued or outstanding as of September 30, 2022 and December 31, 2021)		$	—	$	—
Common stock (par value $0.001 per share; 100,000,000 authorized; 52,838,033 shares issued and 33,947,773 shares outstanding as of September 30, 2022; 52,534,967 shares issued and 33,881,196 shares outstanding as of December 31, 2021)		53		53
Preferred stock (par value $0.001 per share; 8,000,000 authorized; no shares issued or outstanding as of March 31, 2023 and December 31, 2022)						Preferred stock (par value $0.001 per share; 8,000,000 authorized; no shares issued or outstanding as of March 31, 2023 and December 31, 2022)	$	—	$	—
Common stock (par value $0.001 per share; 100,000,000 authorized; 53,275,043 shares issued and 34,159,022 shares outstanding as of March 31, 2023; 53,082,010 shares issued and 34,071,750 shares outstanding as of December 31, 2022)						Common stock (par value $0.001 per share; 100,000,000 authorized; 53,275,043 shares issued and 34,159,022 shares outstanding as of March 31, 2023; 53,082,010 shares issued and 34,071,750 shares outstanding as of December 31, 2022)	53		53
Additional paid-in capital	Additional paid-in capital	393,101		423,235		Additional paid-in capital	410,959		403,866
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(14,217)		(5,843)		Accumulated other comprehensive loss	(15,747)		(17,519)
Treasury stock, at cost (18,890,260 shares as of September 30, 2022; 18,653,771 shares as of December 31, 2021)		(346,471)		(324,412)
Treasury stock, at cost (19,116,021 shares as of March 31, 2023; 19,010,260 shares as of December 31, 2022)						Treasury stock, at cost (19,116,021 shares as of March 31, 2023; 19,010,260 shares as of December 31, 2022)	(362,149)		(354,536)
Retained earnings	Retained earnings	351,804		271,732		Retained earnings	405,063		378,263
Total stockholders’ equity	Total stockholders’ equity	384,270		364,765		Total stockholders’ equity	438,179		410,127
Total liabilities and stockholders’ equity	Total liabilities and stockholders’ equity	$	948,737	$	882,572	Total liabilities and stockholders’ equity	$	981,855	$	995,888

See accompanying notes to interim unaudited condensed consolidated financial statements.

Perficient, Inc.

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except per share information)

Three Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021

Revenues $ 227,614 $ 192,820 $ 672,463 $ 546,297
Cost of revenues (cost of services, exclusive of depreciation and amortization, shown separately below) 136,416 118,260 411,696 337,502
Selling, general and administrative 44,273 39,316 127,384 110,719
Depreciation 2,355 1,607 6,233 4,682
Amortization 6,087 4,317 18,064 17,702
Acquisition costs 2,148 1,264 2,508 1,332
Adjustment to fair value of contingent consideration 3,115 42 (351) 46
Income from operations 33,220 28,014 106,929 74,314
Net interest expense 616 3,481 2,308 10,144
Loss on extinguishment of debt — 250 — 250
Net other expense 20 103 406 234
Income before income taxes 32,584 24,180 104,215 63,686
Provision for income taxes 9,569 6,784 26,282 16,124
Net income $ 23,015 $ 17,396 $ 77,933 $ 47,562
Basic net income per share $ 0.68 $ 0.54 $ 2.30 $ 1.49
Diluted net income per share $ 0.64 $ 0.48 $ 2.17 $ 1.39
Shares used in computing basic net income per share 33,861 31,987 33,873 31,925
Shares used in computing diluted net income per share 36,663 35,893 36,763 34,177


	Three Months Ended
	March 31,
	2023		2022

Revenues	$	231,408	$	222,111


Cost of revenues (cost of services, exclusive of depreciation and amortization, shown separately below)	144,212		138,518
Selling, general and administrative	43,920		42,251
Depreciation	2,305		1,873
Amortization	5,817		5,979
Acquisition costs	79		299
Adjustment to fair value of contingent consideration	(2,026)		(979)
Income from operations	37,101		34,170

Net interest expense	505		887

Net other expense	75		233
Income before income taxes	36,521		33,050
Provision for income taxes	9,721		5,914

Net income	$	26,800	$	27,136

Basic net income per share	$	0.79	$	0.80
Diluted net income per share	$	0.75	$	0.75
Shares used in computing basic net income per share	33,914		33,843
Shares used in computing diluted net income per share	36,697		36,839

See accompanying notes to interim unaudited condensed consolidated financial statements.

Perficient, Inc.

Unaudited Condensed Consolidated Statements of Comprehensive Income

(in thousands)

Three Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021

Net income $ 23,015 $ 17,396 $ 77,933 $ 47,562
Other comprehensive loss:
Foreign currency translation adjustment, net of tax (5,356) (1,401) (8,374) (6,960)
Comprehensive income $ 17,659 $ 15,995 $ 69,559 $ 40,602


	Three Months Ended
	March 31,
	2023		2022

Net income	$	26,800	$	27,136
Other comprehensive income:
Foreign currency translation adjustment, net of tax	1,772		3,806
Comprehensive income	$	28,572	$	30,942

See accompanying notes to interim unaudited condensed consolidated financial statements.

Perficient, Inc.

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

(in thousands)


													Three Months Ended
			Three Months Ended September 30,				Nine Months Ended September 30,						March 31,
			2022		2021		2022		2021				2023		2022

Common Stock	Common Stock										Common Stock
Beginning of period	Beginning of period		$	53	$	51	$	53	$	50	Beginning of period		$	53	$	53
		Stock compensation related to restricted stock vesting and retirement savings plan contributions	—		—		—		1			Stock compensation related to restricted stock vesting and retirement savings plan contributions	—		—
End of period	End of period		53		51		53		51		End of period		53		53
Additional Paid-in Capital	Additional Paid-in Capital										Additional Paid-in Capital
Beginning of period	Beginning of period		383,987		470,218		423,235		459,866		Beginning of period		403,866		423,235
		Proceeds from the sales of stock through the Employee Stock Purchase Plan	257		152		832		363			Proceeds from the sales of stock through the Employee Stock Purchase Plan	240		282
		Stock compensation related to restricted stock vesting and retirement savings plan contributions	5,715		5,006		17,399		15,147			Stock compensation related to restricted stock vesting and retirement savings plan contributions	6,853		5,917
		Issuance of stock in conjunction with acquisition including stock attributed to future compensation	3,142		4,162		3,142		4,162

		Equity component of repurchase of convertible notes, net of tax	—		(8,963)		—		(8,963)
		Proceeds from sale of hedges related to repurchase of convertible notes	—		6,053		—		6,053
		Purchases of warrants related to repurchase of convertible notes	—		(5,042)		—		(5,042)
		Cumulative effect of accounting changes (See Note 3)	—		—		(51,507)		—			Cumulative effect of accounting changes (See Note 3)	—		(51,507)
End of period	End of period		393,101		471,586		393,101		471,586		End of period		410,959		377,927
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss										Accumulated Other Comprehensive Loss
Beginning of period	Beginning of period		(8,861)		(1,813)		(5,843)		3,746		Beginning of period		(17,519)		(5,843)
		Foreign currency translation adjustment	(5,356)		(1,401)		(8,374)		(6,960)			Foreign currency translation adjustment	1,772		3,806
End of period	End of period		(14,217)		(3,214)		(14,217)		(3,214)		End of period		(15,747)		(2,037)
Treasury Stock	Treasury Stock										Treasury Stock
Beginning of period	Beginning of period		(337,237)		(306,270)		(324,412)		(289,225)		Beginning of period		(354,536)		(324,412)
		Purchases of treasury stock and buyback of shares for taxes	(9,234)		(6,104)		(22,059)		(23,149)			Purchases of treasury stock and buyback of shares for taxes	(7,449)		(8,988)

												Stock reacquired for escrow claim	(164)		—
End of period	End of period		(346,471)		(312,374)		(346,471)		(312,374)		End of period		(362,149)		(333,400)
Retained Earnings	Retained Earnings										Retained Earnings
Beginning of period	Beginning of period		328,789		249,807		271,732		219,641		Beginning of period		378,263		271,732
		Cumulative effect of accounting changes (See Note 3)	—		—		2,139		—			Cumulative effect of accounting changes (See Note 3)	—		2,139
		Net income	23,015		17,396		77,933		47,562			Net income	26,800		27,136
End of period	End of period		351,804		267,203		351,804		267,203		End of period		405,063		301,007
Total Stockholders’ Equity	Total Stockholders’ Equity		$	384,270	$	423,252	$	384,270	$	423,252	Total Stockholders’ Equity		$	438,179	$	343,550








		Three Months Ended
		March 31,
Common Stock, shares		2023	2022
Beginning of period		34,072	33,881
	Sales of stock through the Employee Stock Purchase Plan	4	2
	Stock compensation related to restricted stock vesting and retirement savings plan contributions	20	219
	Purchases of treasury stock and buyback of shares for taxes	(106)	(84)
	Issuance of stock in conjunction with acquisition including stock attributed to future compensation	171	—
	Stock reacquired for escrow claim	(2)	—
End of period		34,159	34,018

See accompanying notes to interim unaudited condensed consolidated financial statements.

Three Months Ended September 30, Nine Months Ended September 30,
Common Stock, shares 2022 2021 2022 2021
Beginning of period 33,993 32,071 33,881 32,074
Sales of stock through the Employee Stock Purchase Plan 3 2 8 6
Stock compensation related to restricted stock vesting and retirement savings plan contributions 14 11 246 283
Purchases of treasury stock and buyback of shares for taxes (111) (62) (236) (341)
Issuance of stock in conjunction with acquisition including stock attributed to future compensation 49 43 49 43
End of period 33,948 32,065 33,948 32,065

~~See accompanying notes to interim unaudited condensed consolidated financial statements.~~

Perficient, Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)


		Nine Months Ended September 30,					Three Months Ended March 31,
		2022		2021			2023		2022
Operating Activities	Operating Activities					Operating Activities
Net income	Net income	$	77,933	$	47,562	Net income	$	26,800	$	27,136
Adjustments to reconcile net income to net cash provided by operations:	Adjustments to reconcile net income to net cash provided by operations:					Adjustments to reconcile net income to net cash provided by operations:
Depreciation	Depreciation	6,233		4,682		Depreciation	2,305		1,873
Amortization	Amortization	18,064		17,702		Amortization	5,817		5,979
Loss on extinguishment of debt		—		250

Deferred income taxes	Deferred income taxes	(7,353)		(1,258)		Deferred income taxes	(1,885)		4,087
Non-cash stock compensation and retirement savings plan contributions	Non-cash stock compensation and retirement savings plan contributions	17,733		16,008		Non-cash stock compensation and retirement savings plan contributions	6,674		5,706
Amortization of debt discount and issuance costs		1,822		7,684
Amortization of debt issuance costs						Amortization of debt issuance costs	608		608
Adjustment to fair value of contingent consideration for purchase of businesses	Adjustment to fair value of contingent consideration for purchase of businesses	(351)		46		Adjustment to fair value of contingent consideration for purchase of businesses	(2,026)		(979)

Changes in operating assets and liabilities, net of business acquisitions:	Changes in operating assets and liabilities, net of business acquisitions:					Changes in operating assets and liabilities, net of business acquisitions:
Accounts receivable	Accounts receivable	(12,642)		(30,155)		Accounts receivable	18,784		(8,433)
Other assets	Other assets	(2,153)		(924)		Other assets	5,705		(1,542)
Accounts payable	Accounts payable	(7,288)		(4,830)		Accounts payable	(9,909)		(4,295)
Other liabilities	Other liabilities	(20,557)		(18,632)		Other liabilities	(11,542)		(18,966)
Net cash provided by operating activities	Net cash provided by operating activities	71,441		38,135		Net cash provided by operating activities	41,331		11,174

Investing Activities	Investing Activities					Investing Activities
Purchase of property and equipment	Purchase of property and equipment	(7,019)		(5,892)		Purchase of property and equipment	(1,015)		(2,472)
Capitalization of internally developed software costs	Capitalization of internally developed software costs	(678)		(762)		Capitalization of internally developed software costs	(328)		(175)
Purchase of businesses, net of cash acquired	Purchase of businesses, net of cash acquired	(44,716)		(14,872)		Purchase of businesses, net of cash acquired	28		(67)
Net cash used in investing activities	Net cash used in investing activities	(52,413)		(21,526)		Net cash used in investing activities	(1,315)		(2,714)

Financing Activities	Financing Activities					Financing Activities
Payments for repurchase of convertible notes		—		(13,907)
Proceeds from sale of hedges related to repurchase of convertible notes		—		6,053
Repurchase of warrants related to repurchase of convertible notes		—		(5,042)

Payment for credit facility financing fees	Payment for credit facility financing fees	—		(633)		Payment for credit facility financing fees	(683)		—
Proceeds from line of credit		10,000		—
Payments on line of credit		(10,000)		—

Payment of contingent consideration for purchase of business	Payment of contingent consideration for purchase of business	—		(6,470)		Payment of contingent consideration for purchase of business	(21,530)		—
Proceeds from the sale of stock through the Employee Stock Purchase Plan	Proceeds from the sale of stock through the Employee Stock Purchase Plan	832		363		Proceeds from the sale of stock through the Employee Stock Purchase Plan	240		282
Purchases of treasury stock	Purchases of treasury stock	(13,052)		(17,906)		Purchases of treasury stock	(2,395)		—
Remittance of taxes withheld as part of a net share settlement of restricted stock vesting	Remittance of taxes withheld as part of a net share settlement of restricted stock vesting	(9,007)		(5,243)		Remittance of taxes withheld as part of a net share settlement of restricted stock vesting	(5,054)		(8,988)
Net cash used in financing activities	Net cash used in financing activities	(21,227)		(42,785)		Net cash used in financing activities	(29,422)		(8,706)
Effect of exchange rate on cash and cash equivalents	Effect of exchange rate on cash and cash equivalents	(1,366)		(623)		Effect of exchange rate on cash and cash equivalents	271		11
Change in cash and cash equivalents	Change in cash and cash equivalents	(3,565)		(26,799)		Change in cash and cash equivalents	10,865		(235)
Cash and cash equivalents at beginning of period	Cash and cash equivalents at beginning of period	24,410		83,204		Cash and cash equivalents at beginning of period	30,130		24,410
Cash and cash equivalents at end of period	Cash and cash equivalents at end of period	$	20,845	$	56,405	Cash and cash equivalents at end of period	$	40,995	$	24,175

See accompanying notes to interim unaudited condensed consolidated financial statements.


	Three Months Ended March 31,
	2023		2022
Supplemental Disclosures:
Cash paid for income taxes	$	1,553	$	2,363
Cash paid for interest	$	136	$	226

Non-Cash Investing Activity:
Stock issued for purchase of businesses (stock reacquired for escrow claim)	$	(164)	$	—

See accompanying notes to interim unaudited condensed consolidated financial statements.

Nine Months Ended September 30,
2022 2021
Supplemental Disclosures:
Cash paid for income taxes $ 25,912 $ 14,713
Cash paid for interest $ 697 $ 3,137
Non-Cash Investing Activity:
Stock issued for purchase of businesses $ 2,556 $ 3,803
Liability incurred for purchase of property and equipment $ 3,765 $ —

~~See accompanying notes to interim unaudited condensed consolidated financial statements.~~

PERFICIENT, INC.

NOTES TO INTERIM UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER 30, 2022~~MARCH 31, 2023

1. Basis of Presentation

The accompanying interim unaudited condensed consolidated financial statements of Perficient, Inc. and its subsidiaries (collectively, the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and are presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) applicable to interim financial information. Accordingly, certain note disclosures have been condensed or omitted. In the opinion of management, the interim unaudited condensed consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the periods presented. These financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto filed with the SEC in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2021.~~2022. Certain prior period financial statement amounts have been reclassified to conform to current period presentation.

Through ~~September 30, 2022,~~March 31, 2023, the Company had not experienced a material impact to its business, operations or financial results as a result of ~~the novel coronavirus (COVID-19) pandemic.~~health emergencies and pandemics. However, the Company’s operating results for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 are not necessarily indicative of future results, particularly in light of the ~~COVID-19 pandemic~~health emergencies and ~~its continuing~~pandemics and the related effects on domestic and global economies. For more information, refer to the statements included under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2021.~~2022.

2. Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates, and such differences could be material to the financial statements.

There have been no changes to significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 that have had a material impact on the Company’s condensed consolidated financial statements and related notes ~~other than the changes described in Note 3,~~ ~~Recent Accounting Pronouncements.~~.

3. Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”), which simplifies the accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments, requiring bifurcation only if the convertible debt feature qualifies as a derivative or for convertible debt issued at a substantial premium. The ASU removes certain settlement conditions required for equity contracts to qualify for the derivative scope exception, permitting more contracts to qualify for the exception. In addition, the guidance eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if-converted method. The ASU is effective for annual reporting periods beginning after December 15, 2021, including interim reporting periods within those annual periods. The ASU allows entities to use a modified or full retrospective transition method. Under the modified approach, entities will apply the guidance to all financial instruments that are outstanding as of the beginning of the year of adoption with the cumulative effect recognized as an adjustment to the opening balance of retained earnings. Under the full retrospective method, entities will apply the guidance to all outstanding financial instruments for each prior reporting period presented. The Company adopted this ASU on January 1, 2022 under the modified retrospective method of transition. Upon adoption, the Company recorded a $2.1 million cumulative-effect adjustment that increased the opening balance of retained earnings on the consolidated balance sheet, largely due to the reduction in non-cash interest expense associated with the historical separation of debt and equity components for the Company's convertible senior notes (the “Notes”) described in Note 11, Long-Term Debt. The Company also recorded an increase to long-term debt, net of $66.2 million, a net change in the deferred tax balance of $16.8 million, and a decrease to additional paid-in capital of $51.5 million due to no longer separating the embedded conversion feature of the Notes. Upon adoption, the Company's interest expense recognized has been reduced as a result of accounting for the convertible debt instrument as a single liability measured

at its amortized cost. This adoption did not have a material impact on the consolidated statement of cash flows. Upon adoption, the Company prospectively utilized the if-converted method to calculate the impact of convertible instruments on diluted earnings per share. For the three and nine months ended September 30, 2022, shares used in computing diluted net income per share increased by 2.3 million and 2.2 million shares, respectively, due to the change from the treasury stock method to the if-converted method.

~~In October 2021, the FASB issued ASU No. 2021-08,~~ ~~Business Combinations - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Subtopic 805), which requires an acquirer to recognize and measure contract assets and liabilities acquired in a business combination in accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers,~~ ~~rather than adjust them to fair value at the acquisition date. The Company adopted this ASU on July 1, 2022 and determined the impact of the new guidance on its financial statements was immaterial.~~

4. Revenue

The Company’s revenues consist of services and software and hardware sales. In accordance with ~~ASC~~Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, revenues are recognized when control of services or goods are transferred to clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services or goods.

Services Revenues

Services revenues are primarily comprised of professional services that include developing, implementing, automating and extending business processes, technology infrastructure, and software applications. The Company’s professional services span multiple industries, platforms and solutions; however, the Company has remained relatively diversified and does not believe that it has significant revenue concentration within any single industry, platform or solution.

Professional services revenues are recognized over time as services are rendered. Most projects are performed on a time and materials basis, while a portion of revenues is derived from projects performed on a fixed fee or fixed fee percent complete basis. For time and material contracts, revenues are generally recognized and invoiced by multiplying the number of hours expended in the performance of the contract by the hourly rates. For fixed fee contracts, revenues are generally recognized and invoiced by multiplying the fixed rate per time period established in the contract by the number of time periods elapsed. For fixed fee percent complete contracts, revenues are generally recognized using an input method based on the ratio of hours expended to total estimated hours, and the client is invoiced according to the agreed-upon schedule detailing the amount and timing of payments in the contract.

Clients are typically billed monthly for services provided during that month but can be billed on a more or less frequent basis as determined by the contract. If the time is worked and approved at the end of a fiscal period and the invoice has not yet been sent to the client, the amount is recorded as revenue once the Company verifies all other revenue recognition criteria have been met, and the amount is classified as a receivable as the right to consideration is unconditional at that point. Amounts invoiced in excess of revenues recognized are contract liabilities, which are classified as deferred revenues in the Unaudited Condensed Consolidated Balance Sheet. The term between invoicing and payment due date is not significant. Contracts for professional services provide for a general right, to the client or the Company, to cancel or terminate the contract within a given period of time (generally 10 to 30 days’ notice is required). The client is responsible for any time and expenses incurred up to the date of cancellation or termination of the contract. Certain contracts may include volume discounts or holdbacks, which are accounted for as variable consideration, but are not typically significant. The Company estimates variable consideration based on historical experience and forecasted sales and includes the variable consideration in the transaction price.

Other services revenues are comprised of hosting fees, partner referral fees, maintenance agreements, training and internally developed software-as-a-service (“SaaS”) sales. Revenues from hosting fees, maintenance agreements, training and internally developed SaaS sales are generally recognized over time using a time-based measure of progress as services are rendered. Partner referral fees are recorded at a point in time upon meeting specified requirements to earn the respective fee.

On many professional service projects, the Company is also reimbursed for out-of-pocket expenses including travel and other project-related expenses. These reimbursements are included as a component of the transaction price of the respective professional services contract and are invoiced as the expenses are incurred. The Company structures its professional services arrangements to recover the cost of reimbursable expenses without a markup.

Software and Hardware Revenues

Software and hardware revenues are comprised of third-party software and hardware resales, in which the Company is considered the agent, and sales of internally developed software, in which the Company is considered the principal. Third-party software and hardware revenues are recognized and invoiced when the Company fulfills its obligation to arrange the sale, which occurs when the purchase order with the vendor is executed and the customer has access to the software or the hardware has been shipped to the customer. Internally developed software revenues are recognized and invoiced when control is transferred to the customer, which occurs when the software has been made available to the customer and the license term has commenced. Revenues from third-party software and hardware sales are recorded on a net basis, while revenues from internally developed

software sales are recorded on a gross basis. There are no significant cancellation or termination-type provisions for the Company’s software and hardware sales, and the term between invoicing and payment due date is not significant.

Revenues are presented net of taxes assessed by governmental authorities. Sales taxes are generally collected and subsequently remitted on all software and hardware sales and certain services transactions as appropriate.

Arrangements with Multiple Performance Obligations

Arrangements with clients may contain multiple promises such as delivery of software, hardware, professional services or post-contract support services. These promises are accounted for as separate performance obligations if they are distinct. For arrangements with clients that contain multiple performance obligations, the transaction price is allocated to the separate performance obligations based on estimated relative standalone selling price, which is estimated by the expected cost plus a margin approach, taking into consideration market conditions and competitive factors. Because contracts that contain multiple performance obligations are typically short term due to the contract cancellation provisions, the allocation of the transaction price to the separate performance obligations is not considered a significant estimate.

Contract Costs

In accordance with the terms of the Company’s sales commission plan, commissions are not earned until the related revenue is recognized. Therefore, sales commissions are expensed as they are earned. Certain sales incentives are accrued based on achievement of specified bookings goals. For these incentives, the Company applies the practical expedient that allows the Company to expense the incentives as incurred because the amortization period would have been one year or less.

Deferred Revenue

The Company’s deferred revenue balance as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021~~2022 was ~~$4.5~~$11.3 million and ~~$8.2~~$12.7 million, respectively. ~~Substantially all of~~During the ~~December~~three months ended March 31, ~~2021 deferred revenue balance~~2023, $8.2 million was recognized in revenue ~~during~~that was included in the ~~nine months ended September 30, 2022.~~deferred revenue balance at the beginning of the period.

Transaction Price Allocated to Remaining Performance Obligations

Due to the ability of the client or the Company to cancel or terminate the contract within a given period of time (generally 10 to 30 days’ notice is required), the majority of the Company’s contracts have a term of less than one year. The Company does not disclose the value of unsatisfied performance obligations for contracts with an original maturity date of one year or less or time and materials contracts for which the Company has the right to invoice for services performed. Revenue related to unsatisfied performance obligations for remaining contracts as of ~~September 30, 2022~~March 31, 2023 was immaterial.

Disaggregation of Revenue

The following tables present revenue disaggregated by revenue source and pattern of revenue recognition (in ~~thousands)~~millions):


	Three Months Ended March 31,
	2023						2022
	Over Time		Point In Time		Total Revenues		Over Time		Point In Time		Total Revenues
Time and materials contracts	$	175.5	$	—	$	175.5	$	171.6	$	—	$	171.6
Fixed fee percent complete contracts	14.8		—		14.8		14.4		—		14.4
Fixed fee contracts	36.3		—		36.3		31.2		—		31.2
Reimbursable expenses	2.5		—		2.5		2.0		—		2.0
Total professional services fees	229.1		—		229.1		219.2		—		219.2
Other services revenue*	1.4		0.3		1.7		1.9		0.3		2.2
Total services	230.5		0.3		230.8		221.1		0.3		221.4
Software and hardware	—		0.6		0.6		—		0.7		0.7
Total revenues	$	230.5	$	0.9	$	231.4	$	221.1	$	1.0	$	222.1

1110

Three Months Ended September 30,
2022 2021
Over Time Point In Time Total Revenues Over Time Point In Time Total Revenues
Time and materials contracts $ 176,296 $ — $ 176,296 $ 146,675 $ — $ 146,675
Fixed fee percent complete contracts 11,248 — 11,248 11,572 — 11,572
Fixed fee contracts 35,033 — 35,033 28,678 — 28,678
Reimbursable expenses 2,110 — 2,110 2,316 — 2,316
Total professional services fees 224,687 — 224,687 189,241 — 189,241
Other services revenue* 1,921 436 2,357 2,694 484 3,178
Total services 226,608 436 227,044 191,935 484 192,419
Software and hardware — 570 570 — 401 401
Total revenues $ 226,608 $ 1,006 $ 227,614 $ 191,935 $ 885 $ 192,820

*Other services revenue primarily consists of hosting fees, maintenance, training, internally developed SaaS revenue and partner referral fees.

Nine Months Ended September 30,
2022 2021
Over Time Point In Time Total Revenues Over Time Point In Time Total Revenues
Time and materials contracts $ 518,480 $ — $ 518,480 $ 414,540 $ — $ 414,540
Fixed fee percent complete contracts 39,157 — 39,157 35,252 — 35,252
Fixed fee contracts 99,335 — 99,335 77,726 — 77,726
Reimbursable expenses 6,497 — 6,497 7,132 — 7,132
Total professional services fees 663,469 — 663,469 534,650 — 534,650
Other services revenue* 5,833 1,439 7,272 8,691 1,583 10,274
Total services 669,302 1,439 670,741 543,341 1,583 544,924
Software and hardware — 1,722 1,722 — 1,373 1,373
Total revenues $ 669,302 $ 3,161 $ 672,463 $ 543,341 $ 2,956 $ 546,297

*Other services revenue primarily consists of hosting fees, maintenance, training, internally developed SaaS revenue and partner referral fees.

The following table presents revenue disaggregated by geographic area, as determined by the billing address of customers (in ~~thousands)~~millions):


		Three Months Ended September 30,				Nine Months Ended September 30,					Three Months Ended March 31,
		2022		2021		2022		2021			2023		2022
United States	United States	$	216,362	$	189,334	$	640,287	$	535,491	United States	$	223.5	$	214.7
Other countries	Other countries	11,252		3,486		32,176		10,806		Other countries	7.9		7.4
Total revenues	Total revenues	$	227,614	$	192,820	$	672,463	$	546,297	Total revenues	$	231.4	$	222.1

5. Stock-Based Compensation

Stock-based compensation is accounted for in accordance with ASC Topic 718, Compensation – Stock Compensation. Under this guidance, the Company recognizes share-based compensation ratably using the straight-line attribution method over the requisite service period, which is generally three years. The fair value of restricted stock awards is based on the value of the Company’s common stock on the date of the grant.

Restricted Stock ~~Award Plans~~Awards (“RSAs”)

The Company’s Second Amended and Restated 2012 Long Term Incentive Plan (as amended, the “Incentive Plan”) allows for the granting of various types of stock awards, not to exceed a total of 7.0 million shares, to eligible individuals. The Compensation Committee of the Board of Directors administers the Incentive Plan and determines the terms of all stock awards made under the Incentive Plan. As of ~~September 30, 2022,~~March 31, 2023, there were ~~1.1~~0.7 million shares of common stock available for issuance under the Incentive Plan. On February 21, 2023, the Company’s Board of Directors approved a Third Amended and Restated 2012 Long Term Incentive Plan and approved the submission of the plan to the stockholders for approval at the 2023 annual meeting of the stockholders. If approved by the stockholders, an additional 1.5 million shares of common stock will be available for issuance under the Incentive Plan.

Stock-based compensation cost recognized for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 was ~~$6.1~~$6.8 million, ~~and $18.1 million, respectively,~~ which included $1.1 million ~~and $3.3 million, respectively,~~ of expense for retirement savings plan contributions. The associated current and future income tax benefit recognized was $1.8 million ~~and $4.6 million~~ for the three ~~and nine~~ months ended ~~September 30, 2022, respectively.~~March 31, 2023. Stock-based compensation cost recognized for the three ~~and nine~~ months ended ~~September 30, 2021~~March 31, 2022 was ~~$6.3~~$5.9 million, ~~and $17.1 million, respectively,~~ which included $1.1 million ~~and $3.0 million, respectively,~~ of expense for retirement savings plan contributions. The associated current and future income tax benefit recognized was ~~$1.6 million and $4.1~~$1.1 million for the three ~~and nine~~ months ended ~~September 30, 2021, respectively.~~March 31, 2022. As of ~~September 30, 2022,~~March 31, 2023, there was ~~$27.2~~$44.8 million of total unrecognized compensation cost related to non-vested share-based awards with a weighted-average remaining life of two years.

Restricted stock activity for the ~~nine~~three months ended ~~September 30, 2022~~March 31, 2023 was as follows (shares in thousands):


		Shares	Weighted-Average Grant Date Fair Value			RSAs (Shares)	Weighted-Average Grant Date Fair Value
Restricted stock awards outstanding at December 31, 2021		642	$	55.34
Restricted stock awards outstanding at December 31, 2022					Restricted stock awards outstanding at December 31, 2022	616	$	72.02
Awards granted	Awards granted	152	98.62		Awards granted	237	73.49
Awards vested	Awards vested	(209)	42.11		Awards vested	(171)	64.50
Awards forfeited	Awards forfeited	(30)	64.79		Awards forfeited	(9)	72.04
Restricted stock awards outstanding at September 30, 2022		555	$	71.65
Restricted stock awards outstanding at March 31, 2023					Restricted stock awards outstanding at March 31, 2023	673	$	74.45

6. Net Income per Share

The following table presents the calculation of basic and diluted net income per share (in thousands, except per share information):

Three Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021
Net income, basic $ 23,015 $ 17,396 $ 77,933 $ 47,562
Add back interest expense on convertible notes, net of tax (1) 539 — 1,712 —
Net income, diluted $ 23,554 $ 17,396 $ 79,645 $ 47,562
Basic:
Weighted-average shares of common stock outstanding 33,861 31,987 33,873 31,925
Shares used in computing basic net income per share 33,861 31,987 33,873 31,925
Effect of dilutive securities:
Restricted stock subject to vesting 255 613 298 536
Shares issuable for acquisition consideration (2) 13 66 66 166
Shares issuable for conversion of convertible senior notes (1) 2,431 2,252 2,431 1,515
Shares issuable for exercise of warrants 103 975 95 35
Shares used in computing diluted net income per share 36,663 35,893 36,763 34,177
Basic net income per share $ 0.68 $ 0.54 $ 2.30 $ 1.49
Diluted net income per share $ 0.64 $ 0.48 $ 2.17 $ 1.39


	Three Months Ended
	March 31,
	2023		2022
Net income, basic	$	26,800	$	27,136
Add back interest expense on convertible notes, net of tax	$	560	$	627
Net income, diluted	$	27,360	$	27,763

Basic:
Weighted-average shares of common stock outstanding	33,914		33,843
Shares used in computing basic net income per share	33,914		33,843
Effect of dilutive securities:
Restricted stock subject to vesting	154		372
Shares issuable for acquisition consideration (1)	199		102
Shares issuable for conversion of convertible senior notes	2,430		2,431
Shares issuable for exercise of warrants	—		91
Shares used in computing diluted net income per share	36,697		36,839

Basic net income per share	$	0.79	$	0.80
Diluted net income per share	$	0.75	$	0.75

(1)Upon adoption of ASU 2020-06 on January 1, 2022, the Company prospectively utilized the if-converted method to calculate the impact of convertible instruments on diluted earnings per share. Prior period amounts have not been adjusted due to the adoption of ASU 2020-06 under the modified retrospective method.

~~(2)~~For the three ~~and nine~~ months ended ~~September 30, 2022,~~March 31, 2023, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with Zeon Solutions Incorporated and certain related entities (collectively, “Zeon”); (ii) the Asset Purchase Agreement with Catalyst Networks, Inc. (“Brainjocks”); (iii) the Stock Purchase Agreement with the shareholders of Productora de Software S.A.S. (“PSL”); (iv) the Purchase Agreement with Talos ~~(as defined in Note 9 - Business Combinations)~~LLC, Talos Digital LLC, Talos Digital SAS and TCOMM SAS (“Talos”); (v) the Stock Purchase Agreement with the shareholders of Izmul S.A. (“Overactive”); ~~and~~ (vi) the Stock Purchase Agreement with the shareholders of Inflection Point Systems, Inc. (“Inflection Point”); and (vii) the Purchase Agreement with Ameex Technologies Corporation (“Ameex”), as part of the consideration. For the three ~~and nine~~ months ended ~~September 30, 2021,~~March 31, 2022, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with Zeon; (ii) the Asset Purchase Agreement with ~~MedTouch LLC (“Medtouch~~”);Brainjocks; (iii) ~~the Asset Purchase Agreement with Brainjocks; (iv)~~ the Stock Purchase Agreement with the shareholders of PSL; ~~and (v)~~(iv) the Purchase Agreement with ~~Talos,~~Talos; and (v) the Stock Purchase Agreement with the shareholders Overactive, as part of the consideration.

The number of anti-dilutive securities not included in the calculation of diluted net income per share were as follows (in thousands):


							Three Months Ended
		Three Months Ended September 30,		Nine Months Ended September 30,			March 31,
		2022	2021	2022	2021		2023	2022
Restricted stock subject to vesting	Restricted stock subject to vesting	76	—	78	—	Restricted stock subject to vesting	276	80

Warrants related to the issuance of convertible senior notes	Warrants related to the issuance of convertible senior notes	1,980	—	1,980	4,451	Warrants related to the issuance of convertible senior notes	2,431	1,980
Total anti-dilutive securities	Total anti-dilutive securities	2,056	—	2,058	4,451	Total anti-dilutive securities	2,707	2,060

See Note 11, Long-term Debt for further information on the convertible senior notes and warrants related to the issuance of convertible notes.

~~Prior to 2022, the~~The Company’s Board of Directors authorized the repurchase of up to ~~$315.0~~$375.0 million of Company common stock through a stock repurchase program expiring December 31, 2022. Subsequent to September 30, 2022, the Board of Directors authorized a $60.0 million expansion of the Company’s stock repurchase program for a total repurchase program of $375.0 million and extended the expiration date of the program from December 31, 2022 to December 31, 2024. The program could be suspended or discontinued at any time, based on market, economic, or business conditions. The timing and amount of repurchase transactions will be determined by management based on its evaluation of market conditions, share price, and other factors. Since the program’s inception on August 11, 2008, the Company has repurchased approximately ~~$274.4~~$282.2 million ~~(16.3~~(16.4 million shares) of outstanding common stock through ~~September 30, 2022.~~March 31, 2023.

7. Balance Sheet Components


		September 30, 2022 (unaudited)		December 31, 2021			March 31, 2023 (unaudited)		December 31, 2022
Accounts receivable:	Accounts receivable:	(in thousands)				Accounts receivable:	(in millions)
Billed accounts receivable, net	Billed accounts receivable, net	$	111,899	$	120,892	Billed accounts receivable, net	$	105.1	$	134.5
Unbilled revenues, net	Unbilled revenues, net	81,004		56,710		Unbilled revenues, net	78.4		67.8
Total	Total	$	192,903	$	177,602	Total	$	183.5	$	202.3


Other current assets:	Other current assets:					Other current assets:
Miscellaneous receivables	Miscellaneous receivables	$	1,444	$	1,576	Miscellaneous receivables	$	4.4	$	2.9
Contractual commitment asset	Contractual commitment asset	989		1,736		Contractual commitment asset	2.0		0.9
Federal/state income tax receivable	Federal/state income tax receivable	—		2,504		Federal/state income tax receivable	—		9.2
Other current assets	Other current assets	2,322		1,480		Other current assets	3.1		3.8
Total	Total	$	4,755	$	7,296	Total	$	9.5	$	16.8


Property and equipment:	Property and equipment:					Property and equipment:
Computer hardware (useful life of 3 years)	Computer hardware (useful life of 3 years)	$	24,757	$	21,382	Computer hardware (useful life of 3 years)	$	25.6	$	26.3
Software (useful life of 1 to 7 years)	Software (useful life of 1 to 7 years)	11,788		6,018		Software (useful life of 1 to 7 years)	12.3		11.9
Furniture and fixtures (useful life of 5 years)	Furniture and fixtures (useful life of 5 years)	4,458		4,599		Furniture and fixtures (useful life of 5 years)	4.6		4.7
Leasehold improvements (useful life of 5 years)	Leasehold improvements (useful life of 5 years)	7,808		7,850		Leasehold improvements (useful life of 5 years)	7.7		7.7
Less: Accumulated depreciation	Less: Accumulated depreciation	(30,282)		(25,102)		Less: Accumulated depreciation	(33.4)		(32.6)
Total	Total	$	18,529	$	14,747	Total	$	16.8	$	18.0


Other non-current assets:	Other non-current assets:					Other non-current assets:
Non-current unbilled revenue	Non-current unbilled revenue	$	1,714	$	3,210	Non-current unbilled revenue	$	1.4	$	1.6
Company owned life insurance (“COLI”) asset	Company owned life insurance (“COLI”) asset	9,202		10,807		Company owned life insurance (“COLI”) asset	11.1		10.5
Long term deposits	Long term deposits	1,720		1,653		Long term deposits	1.8		1.9
Credit facility deferred finance fees, net	Credit facility deferred finance fees, net	512		619		Credit facility deferred finance fees, net	1.2		0.5
Other non-current assets	Other non-current assets	15,735		5,629		Other non-current assets	10.4		8.5
Deferred income taxes	Deferred income taxes	18,703		1,340		Deferred income taxes	19.0		18.1
Total	Total	$	47,586	$	23,258	Total	$	44.9	$	41.1


Other current liabilities:
Estimated fair value of contingent consideration liability (Note 9)	$	8.9	$	32.7
Accrued variable compensation	11.2		21.1
Current operating lease liabilities	7.6		10.3
Payroll related costs	8.9		8.9
Deferred revenues	11.3		12.7
Other current liabilities	9.6		9.7
Accrued medical claims expense	2.4		2.9
Professional fees	2.1		2.2
Accrued IT expenses	5.6		4.3
Total	$	67.6	$	104.8


Other non-current liabilities:
Deferred income taxes	$	8.5	$	8.7
Reserve for uncertain tax positions	18.5		17.5
Deferred compensation liability	10.4		9.3
Other non-current liabilities	6.7		5.9
Non-current software accrual	2.0		2.1
Total	$	46.1	$	43.5

1513

Other current liabilities: September 30, 2022 (unaudited) December 31, 2021
Estimated fair value of contingent consideration liability (Note 9) $ 27,848 $ 21,644
Accrued variable compensation 14,044 31,244
Current operating lease liabilities 10,574 11,543
Payroll related costs 9,901 9,523
Deferred revenues 4,512 8,167
Other current liabilities 8,430 5,648
Accrued medical claims expense 3,055 2,605
Professional fees 2,212 1,727
Accrued IT expenses 4,139 1,776
Total $ 84,715 $ 93,877

Other non-current liabilities:
Deferred income taxes $ 8,051 $ 13,075
Reserve for uncertain tax positions 20,951 19,127
Deferred compensation liability 8,363 9,458
Other non-current liabilities 6,155 3,462
Non-current software accrual 2,221 2,710
Total $ 45,741 $ 47,832

8. Allowance for Credit Losses

In accordance with ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, the Company evaluates its allowance based on expected losses rather than incurred losses, which is known as the current expected credit loss model. The allowance is determined using the loss rate approach and is measured on a collective (pool) basis when similar risk characteristics exist. Where financial instruments do not share risk characteristics, they are evaluated on an individual basis. The allowance is based on relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts.

Activity in the allowance for credit losses is summarized as follows (in ~~thousands)~~millions):


		Nine Months Ended September 30,					Three Months Ended March 31,
		2022		2021			2023		2022

Opening balance at January 1	Opening balance at January 1	$	2,944	$	1,065	Opening balance at January 1	$	5.8	$	2.9
Charges to expense, net of recoveries	Charges to expense, net of recoveries	3,205		1,382		Charges to expense, net of recoveries	—		0.3
Other (1)	Other (1)	(449)		(66)		Other (1)	(1.2)		—
Balance at September 30		$	5,700	$	2,381
Balance at March 31						Balance at March 31	$	4.6	$	3.2

(1) Other is primarily related to uncollected balances written off, business acquisitions, and currency translation adjustments.

9. Business Combinations

2022 ~~Acquisition~~Acquisitions

On October 11, 2022, the Company acquired all of the outstanding capital stock of Ameex. Ameex is a digital experience consultancy headquartered in Schaumburg, Illinois, with offshore operations located in Chennai, India. The acquisition of Ameex strengthened the Company’s global delivery capabilities, enhanced agile software design, and further expanded our operations in India. Ameex added more than 400 professionals and strategic client relationships across several industries. The Company’s total allocable purchase price consideration was $36.9 million, net of cash acquired. The Company incurred approximately $1.7 million in transaction costs, which were expensed when incurred. The goodwill is non-deductible for tax purposes.

On September 7, 2022, the Company acquired all of the outstanding capital stock of Inflection Point. Inflection Point is a software consulting and product development firm with nearshore operations based in Monterrey, Mexico, and headquarters in Columbia, Maryland. The acquisition of Inflection Point strengthened the Company’s nearshore delivery capacity, enhanced our digital capabilities, and further expanded our operations across Latin America. Inflection Point added more than 200 professionals and strategic client relationships with customers across several industries. The Company’s total allocable purchase price consideration was ~~$52.6~~$54.0 million, net of cash acquired. The Company incurred approximately $1.6 million in transaction costs, which were expensed when incurred. The goodwill is non-deductible for tax purposes.

The acquisition date fair value of the consideration transferred for the 2022 ~~acquisition~~acquisitions consisted of the following (in millions):


		Inflection Point				Ameex			Inflection Point
Cash, net of cash acquired	Cash, net of cash acquired	$	44.6		Cash, net of cash acquired	$	26.1		$	44.6
Company common stock issued at closing	Company common stock issued at closing	2.6			Company common stock issued at closing	4.2			3.0
Contingent consideration (1)	Contingent consideration (1)	6.6		(2)	Contingent consideration (1)	4.2		(2)	6.6		(3)
Net working capital adjustment due to the seller(s)	Net working capital adjustment due to the seller(s)	(1.2)			Net working capital adjustment due to the seller(s)	2.4			(0.2)
Total allocable purchase price consideration	Total allocable purchase price consideration	$	52.6		Total allocable purchase price consideration	$	36.9		$	54.0

(1)Represents the initial fair value estimate of additional revenue and earnings-based contingent consideration, which may be realized by the sellers 12 months after the closing date of the acquisition.

(2)The maximum cash payout that may be realized by the sellers in the Ameex acquisition is $5.7 million. As of March 31, 2023, the fair value of the contingent consideration was $4.3 million.

(3)The maximum cash payout that may be realized by the sellers in the Inflection Point acquisition is $13.0 million. As of ~~September 30, 2022,~~March 31, 2023, the fair value of the contingent consideration was ~~$6.6~~$4.6 million. The Company recorded a pre-tax

adjustment to reduce the liability in “Adjustment to fair value of contingent consideration” on the Unaudited Condensed Consolidated Statements of Operations of $2.1 million during the three months ended March 31, 2023.

The Company has estimated the preliminary allocation of the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):


	~~Inflection Point~~
~~Acquired tangible assets~~	$	~~3.5~~
~~Identified intangible assets~~	~~20.1~~
~~Liabilities assumed~~	~~(9.0)~~
~~Goodwill~~	~~38.0~~
~~Total allocable purchase price consideration~~	$	~~52.6~~


	Ameex		Inflection Point
Acquired tangible assets	$	7.1	$	3.4
Identified intangible assets	13.2		20.1
Liabilities assumed	(5.2)		(9.9)
Goodwill	21.8		40.4
Total allocable purchase price consideration	$	36.9	$	54.0

The following table presents details as of March 31, 2023 of the intangible assets acquired during the ~~nine months~~year ended ~~September 30,~~December 31, 2022 (dollars in millions).

Weighted Average Useful Life

Estimated Useful Life

~~Inflection Point~~Aggregate Acquisitions

Customer relationships

10 years

~~17.9~~29.9

Customer backlog

1 year

~~1.8~~2.8

Non-compete agreements

5 years

~~0.2~~0.3

Trade name

1 year

~~0.2~~0.3

Total acquired intangible assets

~~20.1~~33.3

The above purchase price accounting estimates for Inflection Point and Ameex are pending finalization of certain acquired tangible and intangible assets, contingent consideration valuation, and a net working capital settlement that is subject to final adjustment as the Company evaluates information during the measurement period.

~~2021 Acquisitions~~

On September 8, 2021, the Company acquired substantially all of the assets of Talos LLC and Talos Digital LLC, each a Delaware limited liability company, and a wholly-owned subsidiary of the Company acquired all of the outstanding capital stock of Talos Digital SAS and TCOMM SAS, each a simplified stock company organized under the laws of the Republic of Colombia (collectively, “Talos”). Talos is a digital transformation consultancy based in Miami, Florida with nearshore delivery centers in Medellin, Colombia. The acquisition of Talos strengthened the Company’s global delivery capabilities, enhanced our nearshore systems and commerce and custom developed solutions customers. Talos added more than 180 professionals and strategic client relationships with customers across several industries. The Company's total allocable purchase price consideration was $27.8 million, net of cash acquired. The Company incurred approximately $1.1 million in transaction costs, which were expensed when incurred. The amount of goodwill deductible for tax purposes, excluding contingent consideration, was $7.5 million.

On October 15, 2021, a wholly-owned subsidiary of the Company acquired Overactive pursuant to the terms of a Stock Purchase Agreement. Overactive is based in Montevideo, Uruguay with nearshore delivery centers in Colombia, Argentina, Uruguay, Chile and Puerto Rico. The acquisition of Overactive expanded the Company’s digital modernization solution services. Overactive added nearly 700 professionals and strategic client relationships with customers across several industries and expanded the Company’s operations in Latin America. The Company’s total allocable purchase price consideration was $110.3 million, net of cash acquired. The Company incurred approximately $2.5 million in transaction costs, which were expensed when incurred. The goodwill is non-deductible for tax purposes.

~~The acquisition date fair value of the consideration transferred for the 2021 acquisitions consisted of the following (in millions):~~

Talos Overactive
Cash, net of cash acquired $ 14.9 $ 93.9
Company common stock issued at closing 3.8 2.4
Contingent consideration (1) 9.0 (2) 12.6 (3)
Net working capital adjustment due to the seller(s) 0.1 1.4
Total allocable purchase price consideration $ 27.8 $ 110.3

~~(1)~~Represents the initial fair value estimate of additional revenue and earnings-based contingent consideration, which may be realized by the sellers 12 months after the applicable closing date of the acquisition.

~~(2)~~The maximum cash payout that may be realized by the sellers in the Talos acquisition is $10.6 million. As of September 30, 2022, the fair value of the contingent consideration was $10.6 million. The Company recorded a pre-tax adjustment in “Adjustment to fair value of contingent consideration” ~~on the Unaudited Condensed Consolidated Statements of Operations to increase the liability $2.1 million and $1.4 million during the three and nine months ended September 30, 2022, respectively.~~

~~(3)~~The maximum cash payout that may be realized by the sellers in the Overactive acquisition is $14.4 million. As of September 30, 2022, the fair value of the contingent consideration was $10.7 million. The Company recorded a pre-tax adjustment in "Adjustment to fair value of contingent consideration" on the Unaudited Condensed Consolidated Statements of Operations to increase the liability $0.9 million and to decrease the liability $2.1 million during the three and nine months ended September 30, 2022, respectively.

~~The Company has allocated of the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):~~

Talos Overactive
Acquired tangible assets $ 2.3 $ 13.8
Identified intangible assets 8.1 35.0
Liabilities assumed (1.8) (18.9)
Goodwill 19.2 80.4
Total allocable purchase price consideration $ 27.8 $ 110.3

~~The following table presents details of the intangible assets acquired during the year ended December 31, 2021 (dollars in millions).~~

~~Weighted Average Useful Life~~

~~Estimated Useful Life~~

~~Aggregate acquisitions~~

~~Customer relationships~~

~~9 years~~

~~6 - 10 years~~

~~39.0~~

~~Customer backlog~~

~~1 year~~

~~3.0~~

~~Non-compete agreements~~

~~5 years~~

~~0.4~~

~~Trade name~~

~~1 year~~

~~0.7~~

~~Total acquired intangible assets~~

~~43.1~~

As the Company completed its evaluation of the acquired assets and assumed liabilities of Talos and Overactive, the Company recorded certain adjustments during the measurement period based on facts and circumstances that existed as of acquisition date. The measurement period adjustments for Talos and Overactive were not material.

Pro-forma Results of Operations

The following presents the unaudited pro-forma combined results of operations of the Company with Overactive for the nine months ended September 30, 2021, after giving effect to certain pro-forma adjustments and assuming Overactive was acquired as of the beginning of 2020. These unaudited pro-forma results include adjustments for Overactive from January 1, 2020 through September 30, 2021. Pro-forma results of operations have not been presented for ~~Talos~~Inflection Point or ~~Inflection Point~~Ameex because the effect of these acquisitions on the Company's condensed consolidated financial statements were not material individually or in the aggregate.

~~These unaudited pro-forma results are presented in compliance with the adoption of ASU No. 2010-29,~~ ~~Business Combinations (Topic 805): Disclosure of Supplementary Pro Forma Information for Business Combinations~~, and are not necessarily indicative of the actual consolidated results of operations had the acquisition of Overactive actually occurred on January 1, 2020 or of future results of operations of the consolidated entities (in thousands, except per share data):


	~~Nine Months Ended September 30,~~
	~~2021~~
~~Revenues~~	$	~~577,602~~
~~Net income~~	$	~~45,598~~
~~Basic net income per share~~	$	~~1.43~~
~~Diluted net income per share~~	$	~~1.33~~
~~Shares used in computing basic net income per share~~	~~31,949~~
~~Shares used in computing diluted net income per share~~	~~34,202~~

10. Goodwill and Intangible Assets

Goodwill represents the excess purchase price over the fair value of net assets acquired, or net liabilities assumed, in a business combination. In accordance with ASC Topic 350, Intangibles – Goodwill and Other, the Company performs an annual impairment review in the fourth quarter and more frequently if events or changes in circumstances indicate that goodwill might be impaired. There was no indication that goodwill became impaired for the three ~~and nine~~ months ended ~~September 30, 2022.~~March 31, 2023.

Other intangible assets include customer relationships, non-compete arrangements, trade names, customer backlog, and developed software, which are being amortized over the assets’ estimated useful lives using the straight-line method. Estimated useful lives range from less than one year to ten years. Amortization of customer relationships, non-compete arrangements, trade names, customer backlog, and developed software is considered an operating expense and is included in “Amortization” in the accompanying Unaudited Condensed Consolidated Statements of Operations. The Company periodically reviews the estimated useful lives of its identifiable intangible assets, taking into consideration any events or circumstances that might result in a lack of recoverability or revised useful life. There was no indication that other intangible assets became impaired for the three ~~and nine~~ months ended ~~September 30, 2022.~~March 31, 2023.

Goodwill

The changes in the carrying amount of goodwill for the ~~nine~~three months ended ~~September 30, 2022~~March 31, 2023 are as follows (in ~~thousands)~~millions):


Balance at December 31, ~~2021~~2022	$	~~515,229~~
~~Purchase price allocation for acquisitions~~	~~37,993~~565.2
Measurement period adjustments for acquisitions	~~993~~2.4
Effect of foreign currency translation adjustments	~~(8,373)~~1.8
Balance at ~~September 30, 2022~~March 31, 2023	$	~~545,842~~569.4

Intangible Assets with Definite Lives

The following table presents a summary of the Company’s intangible assets that are subject to amortization (in ~~thousands)~~millions):


		September 30, 2022						December 31, 2021							March 31, 2023 (unaudited)						December 31, 2022
		Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts		Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts			Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts		Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts
Customer relationships	Customer relationships	$	140,723	$	(63,732)	$	76,991	$	125,433	$	(51,253)	$	74,180	Customer relationships	$	152.5	$	(73.2)	$	79.3	$	151.9	$	(68.4)	$	83.5
Non-compete agreements	Non-compete agreements	1,580		(924)		656		1,444		(736)		708		Non-compete agreements	1.7		(1.1)		0.6		1.7		(1.0)		0.7
Customer backlog	Customer backlog	4,798		(3,042)		1,756		3,025		(741)		2,284		Customer backlog	2.7		(1.4)		1.3		2.7		(0.7)		2.0
Trade name	Trade name	859		(670)		189		683		(155)		528		Trade name	0.9		(0.8)		0.1		0.9		(0.7)		0.2
Developed software	Developed software	7,529		(4,737)		2,792		6,982		(3,405)		3,577		Developed software	8.1		(5.7)		2.4		7.8		(5.3)		2.5
Total	Total	$	155,489	$	(73,105)	$	82,384	$	137,567	$	(56,290)	$	81,277	Total	$	165.9	$	(82.2)	$	83.7	$	165.0	$	(76.1)	$	88.9

The estimated useful lives of identifiable intangible assets are as follows:


Customer relationships			5 - 10 years
Non-compete agreements			4 - 5 years
Customer backlog			1 year
Trade name			1 year
Developed software			1 - 7 years

Estimated annual amortization expense for the next five years ended December 31 and thereafter is as follows (in ~~thousands)~~millions):


2022 remaining		$	5,918
2023		$	17,863
2023 remaining				2023 remaining	$	14.2
2024	2024	$	13,340	2024	$	14.7
2025	2025	$	10,367	2025	$	11.7
2026	2026	$	8,298	2026	$	9.5
2027				2027	$	7.3
Thereafter	Thereafter	$	26,598	Thereafter	$	26.3

11. Long-term Debt

Revolving Credit Facility

On ~~May 7, 2021,~~March 29, 2023, the Company ~~entered~~amended and restated its existing credit agreement by entering into ana Second Amended and Restated Credit Agreement (the ~~“2021~~“2023 Credit ~~Agreement~~”Agreement”) with Wells Fargo Bank, National Association, as administrative agent and the other lenders parties thereto. The ~~2021~~2023 Credit Agreement provides for revolving credit borrowings up to a maximum principal amount of ~~$200.0~~$300.0 million, subject to a commitment increase of $75.0 million. All outstanding amounts owed under the ~~2021~~2023 Credit Agreement become due and payable no later than the final maturity date of ~~May 7, 2026.~~March 29, 2028. As of ~~September 30, 2022,~~March 31, 2023, there was no outstanding balance under the ~~2021~~2023 Credit Agreement. The Company incurred ~~$0.6~~$0.8 million of ~~deferred finance fees as a result of the 2021 Credit Agreement during the nine months ended September 30, 2021. The Company did not incur any~~ additional deferred finance fees during the three ~~and nine~~ months ended ~~September 30, 2022.~~March 31, 2023.

The ~~2021~~2023 Credit Agreement also allows for the issuance of letters of credit in the aggregate amount of up to $10.0 million at any one time; outstanding letters of credit reduce the credit available for revolving credit borrowings. As of ~~September 30, 2022,~~March 31, 2023, the Company had two outstanding letters of credit for $0.2 million. Substantially all of the Company’s assets are pledged to secure the credit facility.

Borrowings under the ~~2021~~2023 Credit Agreement bear interest at the Company’s option of the prime rate ~~(6.25%~~(8.00% on ~~September 30, 2022)~~March 31, 2023) plus a margin ranging from 0.00% to 1.00% or one month ~~LIBOR (3.14%~~Secured Overnight Financing Rate (“SOFR”) (4.87% on ~~September 30, 2022)~~March 31, 2023) plus a margin ranging from 1.00% to 2.00%. The Company incurs an annual commitment fee of 0.15% to 0.20% on the unused portion of the line of credit. The additional margin amount and annual commitment fee are dependent on the level of outstanding borrowings. As of ~~September 30, 2022,~~March 31, 2023, the Company had ~~$199.8~~$299.8 million of unused borrowing capacity.

The Company is required to comply with various financial covenants under the ~~2021~~2023 Credit Agreement. Specifically, the Company is required to maintain a ratio of earnings before interest, taxes, depreciation, and amortization (“EBITDA”) plus stock compensation to interest expense for the previous four consecutive fiscal quarters of not less than 3.50 to 1.00, a ratio of indebtedness less the sum of all unsecured indebtedness, on a consolidated basis and without duplication, less all unrestricted cash and cash equivalents not to exceed $50,000,000 to EBITDA plus stock compensation of not more than 2.50 to 1.00, and a ratio of indebtedness less all unrestricted cash and cash equivalents not to exceed $50,000,000 to EBITDA plus stock compensation (“Consolidated Total Net Leverage Ratio”) of not more than 5.00 to 1.00. Additionally, the 2021 Credit Agreement currently restricts the payment of dividends that would result in a pro-forma Consolidated Total Net Leverage Ratio of more than 3.50 to 1.00.

At ~~September 30, 2022,~~March 31, 2023, the Company was in compliance with all covenants under the ~~2021~~2023 Credit Agreement.

~~Adoption of ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity~~

The Company adopted ASU 2020-06 on January 1, 2022 under the modified retrospective method applied to Notes outstanding as of January 1, 2022 and has not changed previously disclosed amounts or provided additional disclosures for comparative periods. Under ASU 2020-06, convertible instruments with embedded conversion features, that are not required to be accounted for as a derivative or that do not result in a substantial premium, are no longer required to be separated from the host contract thereby eliminating the cash conversion feature model. Instead, these convertible debt instruments will be accounted for as a single liability measured at amortized cost under the traditional convertible debt accounting model.

Convertible Senior Notes due 2026

On November 9, 2021, the Company issued $380.0 million aggregate principal amount of ~~the~~ 0.125% Convertible Senior Notes Due 2026 (the “2026 Notes”) in a private placement to qualified institutional buyers pursuant to an exemption from registration provided by Section 4(a)(2) and Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The net proceeds from the offerings, after deducting the initial purchasers’ discount and issuance costs of $10.7 million, were $369.3 million. The Company used (i) $311.5 million of the net proceeds and 1,640,152 shares of the Company’s common stock to partially repurchase the 2025 Notes (as defined and described below), and (ii) $42.7 million of the net proceeds to fund the cost of entering into the 2026 Notes Hedges (as defined and described below), after such cost was partially offset by the proceeds that the Company received from entering into the 2026 Notes Warrants (as defined and described below). The remaining proceeds of $15.1 million were used for working capital or other general corporate purposes.

The 2026 Notes bear interest at a rate of 0.125% per year. Interest is payable in cash on May 15 and November 15 of each year, with the first payment made on May 15, 2022. The 2026 Notes mature on November 15, 2026 unless earlier converted, redeemed or repurchased in accordance with their terms prior to such date. The initial conversion rate is 5.2100 shares of the Company’s common stock per $1,000 principal amount of 2026 Notes, which is equivalent to an initial conversion price of approximately $191.94 per share of common stock. After consideration of the 2026 Notes Hedges and 2026 Notes Warrants (as defined and described below), the conversion rate is effectively hedged to a price of $295.29 per share of common stock. The conversion rate, and thus the conversion price, may be adjusted under certain circumstances as described in the indenture governing the 2026 Notes (the “2026 Indenture”). The Company may settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election, based on the applicable conversion rate(s). If a “make-whole fundamental change” (as defined in the 2026 Indenture) occurs, then the Company will in certain circumstances increase the conversion rate for a specified period of time. The Company’s intent is to settle the principal amount of the 2026 Notes in cash upon conversion.

In accordance with accounting for debt with conversions and other options prior to the adoption of ASU 2020-06, the Company initially bifurcated the principal amount of the 2026 Notes into liability and equity components. The initial liability component of the 2026 Notes was valued at $313.8 million based on the contractual cash flows discounted at an appropriate comparable market non-convertible debt borrowing rate at the date of issuance of 4.0%. This rate was based on the Company’s estimated rate for a similar liability with the same maturity but without the conversion option. The equity component representing the conversion option and calculated as the residual amount of the proceeds was recorded as an increase in additional paid-in capital within stockholders’ equity of $66.2 million, partially offset by the associated deferred tax effect of $16.9 million. Prior to the adoption of ASU 2020-06, the resulting debt discount of $66.2 million was amortized to interest expense using the effective interest method with an effective interest rate of 4.0% over the period from the issuance date through the contractual maturity date of November 15, 2026.

Issuance costs totaling $10.7 million were initially allocated pro rata based on the relative fair values of the liability and equity components. Issuance costs of $8.8 million attributable to the liability component were recorded as a direct deduction from the carrying value of the 2026 Notes and were amortized to interest expense using the effective interest method over the term of the 2026 Notes. Issuance costs of $1.9 million attributable to the equity component were recorded as a charge to additional paid-in capital within stockholders’ equity, partially offset by the associated deferred tax effect of $0.5 million.

The Company adopted ASU 2020-06 on January 1, 2022 under the modified retrospective method of transition. Upon adoption, the Company recorded a $1.2 million cumulative-effect adjustment that increased the opening balance of retained earnings on the consolidated balance sheet, largely due to the reduction in non-cash interest expense associated with the historical separation of debt and equity components for the 2026 Notes. The Company also recorded an increase to long-term debt, net of $62.6 million, a net change in the deferred tax balance of $15.9 million, and a decrease to additional paid-in capital of $47.9 million due to no longer separating the embedded conversion feature of the 2026 Notes.

Convertible Senior Notes due 2025

On August 14, 2020, the Company issued $230.0 million aggregate principal amount of 1.250% Convertible Senior Notes Due 2025 (the “2025 Notes”) in a private placement to qualified institutional purchasers pursuant to an exemption from registration provided by Section 4(a)(2) and Rule 144A under the Securities Act. The net proceeds from the offerings, after deducting the initial purchasers’ discount and issuance costs of $7.3 million, were $222.7 million. The Company used (i) $172.0 million of the net proceeds to partially repurchase the 2023 Notes (as defined and described below), and (ii) $26.7 million of the net proceeds to fund the cost of entering into the 2025 Notes Hedges (as defined and described below), after such cost was partially offset by the proceeds that the Company received from entering into the 2025 Notes Warrants (as defined and described below). The remaining proceeds of $24.0 million were used for working capital or other general corporate purposes.

The 2025 Notes bear interest at a rate of 1.250% per year. Interest is payable in cash on February 1 and August 1 of each year. The 2025 Notes mature on August 1, 2025 unless earlier converted, redeemed or repurchased in accordance with their terms prior to such date. The initial conversion rate is 19.3538 shares of the Company’s common stock per $1,000 principal amount of 2025 Notes, which is equivalent to an initial conversion price of approximately $51.67 per share of common stock. After consideration of the 2025 Notes Hedges and 2025 Notes Warrants(as defined and described below), the conversion rate is effectively hedged to a price of $81.05 per share of common stock. The conversion rate, and thus the conversion price, may be adjusted under certain circumstances as described in the indenture governing the 2025 Notes (the “2025 Indenture”). The Company may settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election, based on the applicable conversion rate(s). If a “make-whole fundamental change” (as defined in the 2025 Indenture) occurs, then the Company will in certain circumstances increase the conversion rate

for a specified period of time. The Company’s intent is to settle the principal amount of the 2025 Notes in cash upon conversion.

In accordance with accounting for debt with conversions and other options prior to the adoption of ASU 2020-06, the Company initially bifurcated the principal amount of the 2025 Notes into liability and equity components. The initial liability component of the 2025 Notes was valued at $181.1 million based on the contractual cash flows discounted at an appropriate comparable market non-convertible debt borrowing rate at the date of issuance of 6.3%. The equity component representing the conversion option and calculated as the residual amount of the proceeds was recorded as an increase in additional paid-in capital within stockholders’ equity of $48.9 million, partially offset by the associated deferred tax effect of $12.6 million. Prior to the adoption of ASU 2020-06, the resulting debt discount of $48.9 million was amortized to interest expense using the effective interest method with an effective interest rate of 6.3% over the period from the issuance date through the contractual maturity date of ~~August 1, 2025~~.

Issuance costs totaling $7.3 million were initially allocated pro rata based on the relative fair values of the liability and equity components. Issuance costs of $5.7 million attributable to the liability component were recorded as a direct deduction from the carrying value of the 2025 Notes and were amortized to interest expense using the effective interest method over the term of the 2025 Notes. Issuance costs of $1.6 million attributable to the equity component were recorded as a charge to additional paid-in capital within stockholders’ equity, partially offset by the associated deferred tax effect of $0.4 million.

In November and December 2021, the Company repurchased a portion of the outstanding 2025 Notes through individual, privately negotiated transactions (the “2025 Notes Partial Repurchase”), leaving 2025 Notes with aggregate principal amount of $23.3 million outstanding as of December 31, 2021. The Company used $311.5 million of the net proceeds from the 2026 Notes issuance in November 2021, 1,640,152 shares of the Company’s common stock, and $44.0 million of additional cash in December 2021 to complete the 2025 Notes Partial Repurchase, of which a total of $197.4 million and $400.5 million were allocated to the liability and equity components of the 2025 Notes, respectively, and $0.7 million was related to the payment of interest. ~~The amount allocated to equity was partially offset by the associated deferred tax effect of~~ ~~$2.0 million~~. The consideration allocated to the liability component was based on the fair value of the liability component utilizing an effective discount rate of approximately 3.5%. This rate was based on the Company’s estimated rate for a similar liability with the same maturity, but without the conversion option. The consideration allocated to the equity component was calculated by deducting the fair value of the liability component from the aggregate consideration, excluding interest. The Company subsequently compared the allocated consideration with the carrying value of the liability component to record a loss on extinguishment of $21.9 million, which included the proportionate amounts of unamortized debt discount and the remaining unamortized debt issuance costs of $3.8 million. A $6.8 million inducement charge representing the difference between the fair value of the consideration delivered to the holders of the repurchased 2025 Notes and the fair value of the consideration issuable under the original conversion terms was included in “Loss on extinguishment of debt” in the Consolidated Statements of Operations during the year ended December 31, 2021.

Upon adoption of ASU 2020-06 under the modified retrospective method of transition, the Company recorded a $0.9 million cumulative-effect adjustment that increased the opening balance of retained earnings on the consolidated balance sheet, largely due to the reduction in non-cash interest expense associated with the historical separation of debt and equity components for the 2025 Notes. The Company also recorded an increase to long-term debt, net of $3.6 million, a net change in the deferred tax balance of $0.9 million, and a decrease to additional paid-in capital of $3.6 million due to no longer separating the embedded conversion feature of the 2025 Notes.

~~Convertible Senior Notes due 2023~~

On September 11, 2018, the Company issued $143.8 million aggregate principal amount of 2.375% Convertible Senior Notes Due 2023 (the “2023 Notes”) in a private placement to qualified institutional purchasers pursuant to an exemption from registration provided by Section 4(a)(2) and Rule 144A under the Securities Act. The net proceeds from the offerings, after deducting the initial purchasers’ discount and issuance costs of $4.4 million, were $139.4 million.

In August and November 2020, the Company repurchased a portion of the outstanding 2023 Notes through individual, privately negotiated transactions (the “2023 Notes Partial Repurchase”), leaving 2023 ~~Notes with aggregate principal amount of $5.1 million~~ outstanding as of December 31, 2020. The Company used $172.0 million of the net proceeds from the 2025 Notes issuance in August 2020 and $9.7 million of additional cash in November 2020 to complete the 2023 Notes Partial Repurchase, of which a total of $127.7 million and $52.7 million were allocated to the liability and equity components of the 2023 Notes, respectively, and $1.3 million was related to the payment of interest. The cash consideration allocated to the liability component was based on the fair value of the liability component utilizing an effective discount rate of approximately 5.0%. This rate was based on the Company’s estimated rate for a similar liability with the same maturity, but without the conversion option. The

cash consideration allocated to the equity component was calculated by deducting the fair value of the liability component and interest payment from the aggregate cash consideration. The $4.5 million loss on extinguishment was subsequently determined by comparing the allocated cash consideration with the carrying value of the liability component, which includes the proportionate amounts of unamortized debt discount and the remaining unamortized debt issuance costs of $2.4 million.

In August 2021, the Company repurchased the remainder of the outstanding 2023 Notes through individual, privately negotiated transactions (the “Final 2023 Notes Repurchase”). The Company used $13.9 million of cash to complete the Final 2023 Notes Repurchase, of which $4.9 million and $9.0 million were allocated to the liability and equity components of the 2023 Notes, respectively. The amount allocated to equity was partially offset by the associated deferred tax effect of $0.4 million. The Final 2023 Notes Repurchase resulted in a $0.3 million loss on extinguishment during the three and nine months ended September 30, 2021, which included the proportionate amounts of unamortized debt discount and the remaining unamortized debt issuance costs of $0.1 million.

Other Terms of the Notes

The 2025 Notes and 2026 Notes may be converted at the holder’s option prior to the close of business on the business day immediately preceding August 1, 2025 for the 2025 Notes and November 15, 2026 for the 2026 Notes, but only under the following circumstances:

•during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 for the 2025 Notes and December 31, 2021 for the 2026 Notes, if the last reported sale price per share of the Company’s common stock exceeds 130% of the applicable conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter;

•during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Company’s common stock on such trading day and the applicable conversion rate on such trading day;

•upon the occurrence of certain corporate events or distributions on the Company’s common stock described in the 2025 Indenture and 2026 Indenture; and

•at any time from, and including, February 3, 2025 for 2025 Notes and May 15, 2026 for 2026 Notes, until the close of business on the second scheduled trading day immediately before the maturity date for the 2025 Notes and 2026 Notes.

The Company may not redeem the 2025 Notes and 2026 Notes at its option before maturity. If a “fundamental change” (as defined in the 2025 Indenture and 2026 Indenture) occurs, then, except as described in the 2025 Indenture and 2026 Indenture, noteholders may require the Company to repurchase their 2025 Notes and 2026 Notes at a cash repurchase price equal to the principal amount of the 2025 Notes and 2026 Notes to be repurchased, plus accrued and unpaid interest, if any.

During the three months ended ~~September 30, 2022, when~~March 31, 2023, the conditional conversion features of the 2025 Notes were triggered as the last reported sale price of the Company's common stock was greater than or equal to 130% of the conversion price for at least 20 trading days in the period of 30 consecutive trading days ended on March 31, 2023 (the last trading day of the fiscal quarter). Therefore, the 2025 Notes are currently convertible, in ~~accordance with their terms, one~~whole or in part, at the option of the holder during the quarter ending June 30, 2023. Whether the 2025 Notes will be convertible following such period will depend on the continued satisfaction of this condition or another conversion condition in the future. Since the Company has the election of repaying the 2025 Notes in cash, shares of the Company’s common stock, or a combination of both, the Company continued to classify the 2025 Notes as long-term debt on the Condensed Consolidated Balance Sheet as of March 31, 2023 (unaudited). As of the date of this filing, none of the current holders of the 2025 Notes as of March 31, 2023 have submitted ~~a request~~requests for conversion. ~~The conversion is immaterial and will be settled in cash in December 2022.~~ As of ~~September 30, 2022,~~March 31, 2023, none of the conditions permitting holders to convert their ~~2025 Notes or~~ 2026 Notes ~~were not~~had been satisfied and no shares of the Company’s common stock ~~were~~had been issued in connection with any conversions of the ~~2025 Notes or~~ 2026 ~~Notes, other than shares issued in conjunction with the 2025 Notes Partial Repurchase.~~Notes. Based on the closing price of the ~~Company’s~~Company's common stock of ~~$65.02~~$72.19 per share on ~~September 30, 2022,~~March 31, 2023, the conversion value of the 2026 Notes was less than the principal amount of the 2026 Notes outstanding on a per note basis, and the conversion value of the 2025 Notes ~~and 2026 Notes were less~~was greater than the principal amount of the 2025 Notes ~~and 2026 Notes~~ outstanding on a per note ~~basis, respectively.~~basis.

The ~~liability component of the~~ 2025 Notes and 2026 Notes consisted of the following (in ~~thousands)~~millions):


		September 30, 2022 (unaudited)				March 31, 2023 (unaudited)
Liability component:		2026 Notes		2025 Notes
Long-term debt:							Long-term debt:	2026 Notes		2025 Notes
Principal	Principal	$	380,000	$	23,293		Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	Less: Unamortized debt issuance costs	(8,825)		(418)			Less: Unamortized debt issuance costs	(7.8)		(0.3)
Net carrying amount	Net carrying amount	$	371,175	$	22,875		Net carrying amount	$	372.2	$	23.0

December 31, 2021
Liability component: 2026 Notes 2025 Notes
     Principal $ 380,000 $ 23,293
     Less: Unamortized debt discount (1) (64,413) (3,724)
               Unamortized debt issuance costs (8,613) (417)
Net carrying amount $ 306,974 $ 19,152

~~(1) As noted above, prior period amounts have not been adjusted due to the adoption of ASU 2020-06 under the modified retrospective method.~~


	December 31, 2022
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3

Less: Unamortized debt issuance costs	(8.3)		(0.4)
Net carrying amount	$	371.7	$	22.9

Interest expense for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ related to the 2026 Notes and 2025 Notes consisted of the following (in ~~thousands)~~millions):

2026 Notes


											Three Months Ended
		Three Months Ended September 30,				Nine Months Ended September 30,					March 31,
		2022		2021		2022		2021			2023		2022
Coupon interest	Coupon interest	$	119	$	—	$	357	$	—	Coupon interest	$	0.1	$	0.1
Amortization of debt discount (1)		—		—		—		—

Amortization of debt issuance costs	Amortization of debt issuance costs	535		—		1,605		—		Amortization of debt issuance costs	0.6		0.6
Total interest expense recognized	Total interest expense recognized	$	654	$	—	$	1,962	$	—	Total interest expense recognized	$	0.7	$	0.7

2025 Notes

Three Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021
Coupon interest $ 73 $ 718 $ 219 $ 2,156
Amortization of debt discount (1) — 2,246 — 6,625
Amortization of debt issuance costs 37 291 111 866
Total interest expense recognized $ 110 $ 3,255 $ 330 $ 9,647

~~(1) As noted above, prior period amounts have not been adjusted due to the adoption of ASU 2020-06 under the modified retrospective method.~~


	Three Months Ended
	March 31,
	2023		2022
Coupon interest	$	0.1	$	0.1

Amortization of debt issuance costs	—		—
Total interest expense recognized	$	0.1	$	0.1

Convertible Notes Hedges

In connection with the issuance of the 2026 Notes ~~2025 Notes,~~ and ~~2023~~2025 Notes, the Company entered into privately negotiated convertible note hedge transactions (the “2026 Notes Hedges”, and the “2025 Notes Hedges”), ~~and the “2023 Notes Hedges,” respectively,~~ and together, the “Notes Hedges”) with certain of the initial purchasers or their respective affiliates and/or other financial institutions (the “Option Counterparties”). ~~The~~As of March 31, 2023, the 2026 Notes Hedges provide the Company with the option to acquire, on a net settlement basis, approximately 2.0 million shares of common stock at a strike price of $191.94, which is equal to the number of shares of common stock that notionally underlie the 2026 Notes and correspond to the conversion price of the 2026 Notes. ~~Upon initial purchase,~~As of March 31, 2023, the 2025 Notes Hedges provided the Company with the option to acquire, on a net settlement basis, approximately ~~4.5~~0.5 million shares of common stock at a strike price of $51.67, which is equal to the number of shares of common stock that notionally underlie the 2025 Notes and correspond to the conversion price of the 2025 Notes. If the Company elects cash settlement and exercises the Notes Hedges, the aggregate amount of cash received from the Option Counterparties will cover the aggregate amount of cash that the Company would be required to pay to the holders of the Notes, less the principal amount thereof. The Notes Hedges do not meet the criteria for separate accounting as a derivative as they are indexed to the Company’s stock and are accounted for as freestanding financial instruments. Upon initial purchase, the 2025 Notes Hedges and 2026 Notes Hedges were recorded as a reduction in additional paid-in capital within stockholders’ equity of $48.9 million and $66.1 million, respectively, partially offset by the deferred tax effect of $12.6 million and $16.8 million, respectively. ~~In August and November 2020, in connection with the 2023 Notes Partial Repurchase, the Company terminated~~

~~2023 Notes Hedges corresponding to approximately~~ ~~3.7 million~~ ~~shares for cash proceeds of~~ ~~$50.1 million. In August 2021, in connection with the Final 2023 Notes Repurchase, the Company terminated the remainder of the 2023 Notes Hedges corresponding to approximately~~ ~~0.1 million~~ ~~shares for cash proceeds of~~ ~~$6.1 million. In November and December 2021, in connection with the 2025 Notes Partial Repurchase, the Company partially repurchased 2025 Notes Hedges corresponding to approximately~~ ~~4.0 million~~ ~~shares for cash proceeds of $375.2 million. The proceeds were recorded as an increase to additional paid-in capital within stockholders’ equity.~~

Convertible Notes Warrants

In connection with the issuance of the 2026 Notes ~~2025 Notes,~~ and ~~2023~~2025 Notes, the Company also sold net-share-settled warrants (the “2026 Notes Warrants”, ~~the “2025 Notes Warrants”,~~ and the ~~“2023~~“2025 Notes Warrants,” respectively, and together, the “Notes Warrants”) in privately negotiated transactions with the Option Counterparties. The strike price of the 2026 Notes Warrants ~~2025 Notes Warrants,~~ and ~~2023~~2025 Notes Warrants was approximately $295.29 and $81.05 ~~and $46.62~~ per share, respectively, and is subject to certain adjustments under the terms of their respective Notes Warrants. As a result of the 2026 Notes Warrants ~~2025 Notes Warrants,~~ and ~~2023~~2025 Notes Warrants and related transactions, the Company is required to recognize incremental dilution of earnings per share to the extent the average share price for any fiscal quarter is over $295.29 for the 2026 Notes Warrants and $81.05 for the 2025 ~~Notes Warrants, and $46.62 for the 2023~~ Notes Warrants. The 2026 Notes Warrants and the 2025 Notes Warrants expire over a period of 80 trading days commencing on February 15, 2027 and over a period of 100 trading days commencing on November 1, 2025, respectively, and may be settled in net shares of common stock or net cash at the Company’s election. ~~Upon initial sale, the 2025 Notes Warrants~~As of March 31, 2023, 2.0 million warrant shares and 0.5 million warrant shares were outstanding for the 2026 Notes Warrants ~~were recorded as an increase in additional paid-in capital within stockholders’ equity of~~ ~~$22.2 million~~and~~$23.4 million, respectively.~~ ~~In August and November 2020, in connection with the 2023 Notes Partial Repurchase, the Company repurchased a portion of the 2023 Notes Warrants through a cash payment of~~ ~~$43.0 million~~. In August 2021, in connection with the Final 2023 Notes Repurchase, the Company repurchased the remainder of the 2023 Notes Warrants through a cash payment of $5.0 million. In November and December 2021, in connection with the 2025 Notes Partial Repurchase, the Company partially repurchased 2025 Notes Warrants, ~~through cash payments of $298.9 million. The repurchases were recorded as reductions to additional paid-in capital within stockholders’ equity.~~respectively.

12. Income Taxes

The Company's effective tax rate was ~~29.4% and 25.2%~~26.6% for the three ~~and nine~~ months ended ~~September 30, 2022, respectively. The Company's effective tax rate~~March 31, 2023, which was ~~28.1% and 25.3% for the three and nine months ended September 30, 2021, respectively. The effective tax rates for the three and nine months ended September 30, 2022 and 2021 were~~ higher than the U.S. statutory rate of 21.0% primarily due to state taxes ~~Section 162(m) compensation limitations~~ and foreign ~~operations, partially offset by~~operations. The Company's effective tax rate was 17.9% for the three months ended March 31, 2022, which was lower than the U.S. statutory rate of 21.0% primarily due to tax benefits for ~~share based~~share-based compensation ~~deductions and research credits.~~deductions.

The Company’s 2016-2019 U.S. income tax returns are currently under examination by the Internal Revenue Service (the “IRS”). The IRS has sought to disallow research credits of $5.7 million on the Company’s 2011-2015 U.S. income tax returns. The Company has exhausted all administrative appeals and formal mediation and has currently engaged in pre-trial motions to resolve this dispute. The Company believes the research credits taken are appropriate and intends to vigorously defend its position. An amount of adjustment, if any, and the timing of such adjustment are not reasonably possible to estimate at this time. The total amount of research credits taken or expected to be taken on the Company’s income tax returns for 2011 through September 30, 2022 is $30.6 million.

13. Derivatives

In the normal course of business, the Company uses derivative financial instruments to manage foreign currency exchange rate risk. Currency exposure is monitored and managed by the Company as part of its risk management program which seeks to reduce the potentially adverse effects that market volatility could have on operating results. The Company’s derivative financial instruments consist of non-deliverable and deliverable foreign currency forward contracts. Derivative financial instruments are neither held nor issued by the Company for trading purposes.

Derivatives Not Designated as Hedging Instruments

Both the gain or loss on the derivatives not designated as hedging instruments and the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings. Realized gains or losses and changes in the estimated fair value of foreign currency forward contracts that have not been designated as hedges were a net ~~loss~~gain of ~~$1.0 million and a net loss of $0.9~~$0.4 million during the three ~~and nine~~ months ended ~~September 30, 2022, respectively.~~March 31, 2023. Realized gains or losses and changes in the estimated fair value of foreign currency forward contracts that have not been designated as

hedges were a net ~~loss~~gain of ~~$0.3 million and a net loss of $1.0~~$0.9 million during the three ~~and nine~~ months ended ~~September 30, 2021, respectively.~~March 31, 2022. Gains and losses on these contracts are recorded in net other expense (income) and net interest expense in the Unaudited Condensed Consolidated Statements of Operations and are offset by losses and gains on the related hedged items.

The notional amounts of the Company’s derivative instruments outstanding were as follows (in ~~thousands)~~millions):


		September 30, 2022 (unaudited)		December 31, 2021			March 31, 2023 (unaudited)		December 31, 2022
Derivatives not designated as hedges	Derivatives not designated as hedges					Derivatives not designated as hedges
Foreign exchange contracts	Foreign exchange contracts	$	25,930	$	24,223	Foreign exchange contracts	$	33.0	$	31.0
Total derivatives not designated as hedges	Total derivatives not designated as hedges	$	25,930	$	24,223	Total derivatives not designated as hedges	$	33.0	$	31.0

14. Fair Value Measurements

The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair value that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions.

The fair value hierarchy consists of the following three levels:

•Level 1 – Inputs are quoted prices in active markets for identical assets or liabilities.

•Level 2 – Inputs are quoted prices for similar assets or liabilities in an active market, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable and market-corroborated inputs which are derived principally from or corroborated by observable market data.

•Level 3 – Inputs are derived from valuation techniques in which one or more significant inputs or value drivers are unobservable.

The carrying value of cash and cash equivalents, accounts receivable, accounts payable, current liabilities and the revolving line of credit approximate fair value because of the short maturity of these instruments.

All highly liquid investments with maturities at date of purchase of three months or less are considered to be cash equivalents. Based on their short-term nature, the carrying value of cash equivalents approximate their fair value. As of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021, $0.8~~2022, $21.4 million and ~~$12.1~~$8.4 million, respectively, of the Company’s cash and cash equivalents balance related to money-market fund investments. These short-term money-market funds are considered Level 1 investments.

The Company has a deferred compensation plan, which is funded through COLI policies. The COLI asset is carried at fair value derived from quoted market prices of investments within the COLI policies, which are considered Level 2 inputs. The fair value of the COLI asset was ~~$9.2~~$11.1 million and ~~$10.8~~$10.5 million as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021,~~2022, respectively.

The Company estimates the fair value of each foreign exchange forward contract by using the present value of expected cash flows. The estimate takes into account the difference between the current market forward price and contracted forward price for each foreign exchange contract and applies the difference in the rates to each outstanding contract. Valuations for all derivatives fall within Level 2 of the GAAP valuation hierarchy. The fair values of the Company’s derivative instruments outstanding as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021~~2022 were immaterial.

The Company has contingent consideration liabilities related to acquisitions which are measured on a recurring basis and recorded at fair value, determined using the discounted cash flow method. The inputs used to calculate the fair value of the contingent consideration liabilities are considered to be Level 3 inputs due to the lack of relevant market activity and significant management judgment. An increase in future cash flows may result in a higher estimated fair value while a decrease in future cash flows may result in a lower estimated fair value of the contingent consideration liabilities. Remeasurements to fair value are recorded in adjustment to fair value of contingent consideration in the Unaudited Condensed Consolidated Statements of

Operations. Refer to Note 7, Balance Sheet Components, for the estimated fair value of the contingent consideration liabilities as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021.~~2022.

The fair value of the Notes is measured using quoted price inputs. The Notes are not actively traded, and thus the price inputs represent a Level 2 measurement. As the quoted price inputs are highly variable from day to day, the fair value estimates could significantly increase or decrease.

The Notes are carried at their principal amount less unamortized issuance costs, and are not carried at fair value at each period end. The approximate fair value of the 2026 Notes as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021~~2022 was ~~$284.2~~$305.9 million and ~~$363.6~~$295.5 million, respectively. The approximate fair value of the 2025 Notes as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021~~2022 was ~~$31.8~~$34.7 million and ~~$59.6~~$33.8 million, respectively. The fair values were estimated on the basis of inputs that are observable in the market and are considered Level 2 fair value measurements.

15. Leases

The Company leases office space under various operating lease agreements, which have remaining lease terms of less than one year to eight years. Operating leases are included in operating lease right-of-use assets, other current liabilities, and operating lease liabilities on the consolidated balance sheet. Operating lease expense for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 was ~~$3.2~~$3.3 million, and ~~$9.6 million, respectively, and $3.1 million and $9.7~~$3.2 million for the three ~~and nine~~ months ended ~~September 30, 2021, respectively.~~March 31, 2022.

Supplemental balance sheet information related to leases was as follows (in ~~thousands)~~millions):


		September 30, 2022		December 31, 2021			March 31, 2023 (unaudited)		December 31, 2022
Other current liabilities	Other current liabilities	$	10,574	$	11,543	Other current liabilities	$	7.6	$	10.3
Operating lease liabilities	Operating lease liabilities	20,661		23,898		Operating lease liabilities	20.3		18.5
Total	Total	$	31,235	$	35,441	Total	$	27.9	$	28.8

Future minimum lease payments as of ~~September 30, 2022~~March 31, 2023 were as follows (in ~~thousands)~~millions):


		September 30, 2022			March 31, 2023 (unaudited)
2022 remaining		$	2,059
2023		9,036
2023 remaining				2023 remaining	$	5.8
2024	2024	7,436		2024	8.2
2025	2025	5,675		2025	6.0
2026	2026	3,304		2026	3.6
2027				2027	3.3
Thereafter	Thereafter	6,061		Thereafter	3.2
Total future lease payments	Total future lease payments	33,571		Total future lease payments	30.1
Less implied interest	Less implied interest	(2,336)		Less implied interest	(2.2)
Total	Total	$	31,235	Total	$	27.9

16. Commitments and Contingencies

From time to time the Company is involved in legal proceedings, claims and litigation related to employee claims, contractual disputes and taxes in the ordinary course of business. Although the Company cannot predict the outcome of such matters, currently the Company has no reason to believe the disposition of any current matter could reasonably be expected to have a material adverse impact on the Company’s financial position, results of operations or the ability to carry on any of its business activities.

~~17. Subsequent Event~~

On October 11, 2022, the Company entered into a Stock Purchase Agreement (the “Ameex Agreement”), by and among the Company, Ameex Technologies Corporation (“Ameex”), the shareholders of Ameex (the “Shareholders”), and certain other parties thereto. Pursuant to the Ameex Agreement, the Company acquired all of the outstanding capital stock of Ameex.

The total consideration paid at closing was approximately $32.3 million, comprised of (1) $27.1 million in cash and (2) $5.2 million in the Company’s common stock (based on the average closing price of the Company’s common stock on the Nasdaq Global Select Market for the 30 trading days immediately preceding the closing date per the terms of the Ameex Agreement). Of the total consideration, $4.8 million was placed in escrow as security for post-closing indemnification obligations of the Shareholders.

The purchase price is subject to a net working capital adjustment and contingent consideration of up to $5.7 million payable in cash and contingent on the satisfaction of certain post-closing financial performance objectives of Ameex during the 12-month period immediately following closing. The Ameex Agreement includes customary representations, warranties and covenants by the parties.

This transaction will be accounted for as a business combination under the acquisition method of accounting. The Company will record the assets acquired and liabilities assumed at their fair values as of the acquisition date. Due to the limited time since the closing of the acquisition, the valuation efforts and related acquisition accounting are incomplete at the time of filing of the Interim Unaudited Condensed Consolidated Financial Statements. As a result, the Company is unable to provide amounts recognized as of the acquisition date for major classes of assets and liabilities acquired, including goodwill and other intangible assets.

2922

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Statements made in this Form 10-Q, including without limitation this Management’s Discussion and Analysis of Financial Condition and Results of Operations, other than statements of historical information, are forward looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements may sometimes be identified by such words as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of those words and other comparable words. We believe that it is important to communicate our future expectations to investors. However, these forward-looking statements involve many risks and uncertainties. Our actual results could differ materially from those indicated in such forward-looking statements as a result of certain factors, including but not limited to, those set forth under “Risk Factors” in our Annual Report on Form 10-K previously filed with the SEC and elsewhere in this Form 10-Q. We are under no duty to update any of the forward-looking statements after the date of this Form 10-Q to conform these statements to actual results. For additional information, see the “Special Note Regarding Forward-Looking Statements” contained in this Form 10-Q.

Overview

Perficient is a global digital consultancy transforming how the world’s biggest brands connect with customers and grow their businesses. We help clients, primarily focused in North America, gain competitive advantage by using digital technology to: make their businesses more responsive to market opportunities; strengthen relationships with customers, suppliers, and partners; improve productivity; and reduce information technology costs. With unparalleled strategy, creative and technology capabilities, across industries, our end-to-end digital consulting services help our clients drive faster speed-to-market capabilities and stronger, more compelling experiences for consumers. We go to market with six primary service categories – strategy and ~~consulting,~~transformation, data and intelligence, platforms and technology, customer experience and ~~design,~~digital marketing, innovation and product development, ~~platforms and technology, data and intelligence,~~ and optimized global delivery. Within each service category, and collectively, we deliver a deep and broad portfolio of solutions that enable our clients to operate a real-time enterprise that dynamically adapts business processes and the systems that support them to meet the changing demands of a global and competitive marketplace.

~~COVID-19 Pandemic~~

Through September 30, 2022, we have not experienced a material impact to our business, operations or financial results as a result of the pandemic. We continue to monitor closely the Company’s financial health and liquidity and the impact of the pandemic on the Company, including emerging variants. See “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 previously filed with the SEC for additional information regarding the potential impact of COVID-19 on the Company.

Services Revenues

Services revenues are derived from professional services that include developing, implementing, integrating, automating and extending business processes, technology infrastructure, and software applications. Professional services revenues are recognized over time as services are rendered. Most of our projects are performed on a time and materials basis, while a portion of our revenues is derived from projects performed on a fixed fee or fixed fee percent complete basis. For time and material projects, revenues are recognized and billed by multiplying the number of hours our professionals expend in the performance of the project by the hourly rates. For fixed fee contracts, revenues are recognized and billed by multiplying the established fixed rate per time period by the number of time periods elapsed. For fixed fee percent complete projects, revenues are generally recognized using an input method based on the ratio of hours expended to total estimated hours. Fixed fee percent complete engagements represented ~~5% and~~ 6% of our services revenues for the three ~~and nine~~ months ended ~~September 30, 2022, respectively,~~March 31, 2023, and 6% for the three ~~and nine~~ months ended ~~September 30, 2021.~~March 31, 2022. On most projects, we are reimbursed for out-of-pocket expenses including travel and other project-related expenses. These reimbursements are included as a component of the transaction price of the respective professional services contract. The aggregate amount of reimbursed expenses will fluctuate depending on the location of our clients, the total number of our projects that require travel, the impact of travel restrictions imposed as a result of ~~the COVID-19 pandemic,~~health emergencies and pandemics, and whether our arrangements with our clients provide for the reimbursement of such expenses. In conjunction with services provided, we occasionally receive referral fees under partner programs. These referral fees are recognized at a point in time when earned and recorded within services revenues.

Software and Hardware Revenues

Software and hardware revenues are derived from sales of third-party software and hardware resales, in which we are considered the agent, and sales of internally developed software, in which we are considered the principal. Revenues from sales of third-party software and hardware are recorded on a net basis, while revenues from internally developed software sales are recorded on a gross basis. Software and hardware revenues are expected to fluctuate depending on our clients’ demand for these ~~products, which may be impacted by the COVID-19 pandemic.~~products.

There are no significant cancellation or termination-type provisions for our software and hardware sales. Contracts for our professional services provide for a general right, to the client or us, to cancel or terminate the contract within a given period of time (generally 10 to 30 days’ notice is required). The client is responsible for any time and expenses incurred up to the date of cancellation or termination of the contract.

Cost of Revenues

Cost of revenues consists of cost of services, primarily related to cash and non-cash compensation and benefits (including bonuses and non-cash compensation related to equity awards), costs associated with subcontractors, reimbursable expenses and other project-related expenses. Cost of revenues does not include depreciation of assets used in the production of revenues which are primarily personal computers, servers, and other information technology related equipment. In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, sales of third-party software and hardware are presented on a net basis, and as such, third-party software and hardware costs are not presented within cost of revenues.

Our cost of services as a percentage of services revenues is affected by the utilization rates of our professionals (defined as the percentage of our professionals’ time billed to clients divided by the total available hours in the respective period), the salaries we pay our professionals, and the average billing rate we receive from our clients. If a project ends earlier than scheduled, we retain professionals in advance of receiving project assignments, or demand for our services declines, our utilization rate will decline and adversely affect our cost of services as a percentage of services revenues.

Selling, General, and Administrative Expenses

Selling, general and administrative (“SG&A”) expenses are primarily composed of sales-related costs, general and administrative salaries, stock compensation expense, office costs, recruiting expense, variable compensation costs, marketing costs and other miscellaneous expenses. We have access to sales leads generated by our software vendors whose products we use to design and implement solutions for our clients. These relationships enable us to optimize our selling costs and sales cycle times and increase win rates through leveraging our partners’ marketing efforts and endorsements.

Plans for Growth and Acquisitions

Our goal is to continue to build one of the leading information technology consulting firms by expanding our relationships with existing and new clients and through the continuation of our disciplined acquisition strategy. Our future growth plan includes expanding our business with a primary focus on customers in the United States, both organically and through acquisitions. We also intend to further leverage our existing offshore and nearshore capabilities to support our future growth and provide our clients flexible options for project delivery. Our ability to continue to implement our growth plan ~~and evaluate potential acquisitions~~ may be negatively affected by the impact of ~~the COVID-19 pandemic.~~health emergencies and pandemics on our operations, and our ability to evaluate potential acquisitions.

When analyzing revenue growth by base business compared to acquired companies in the Results of Operations section below, revenue attributable to base business includes revenue from an acquired company that has been owned for a full four quarters after the date of acquisition.

Results of Operations

Three months ended ~~September 30, 2022~~March 31, 2023 compared to three months ended ~~September 30, 2021~~March 31, 2022

Revenues. Total revenues increased ~~18.0%~~4.2% to ~~$227.6~~$231.4 million for the three months ended ~~September 30, 2022~~March 31, 2023 from ~~$192.8~~$222.1 million for the three months ended ~~September 30, 2021.~~March 31, 2022.


		Financial Results (in thousands)						Explanation for Increases Over Prior Year Period (in thousands)					Financial Results (in millions)						Explanation for Increases (Decreases) Over Prior Year Period (in millions)
		Three Months Ended September 30,				Total Increase Over Prior Year Period		Increase Attributable to Revenue Delivered by Resources of Acquired Companies		Increase Attributable to Revenue Delivered by Base Business Resources			Three Months Ended March 31,				Total Increase (Decrease) Over Prior Year Period		Increase Attributable to Revenue Delivered by Resources of Acquired Companies		Increase (Decrease) Attributable to Revenue Delivered by Base Business Resources
		2022		2021									2023		2022
Services revenues	Services revenues	$	227,044	$	192,419	$	34,625	$	16,471	$	18,154	Services revenues	$	230.8	$	221.4	$	9.4	$	8.9	$	0.5
Software and hardware revenues	Software and hardware revenues	570		401		169		—		169		Software and hardware revenues	0.6		0.7		(0.1)		—		(0.1)
Total revenues	Total revenues	$	227,614	$	192,820	$	34,794	$	16,471	$	18,323	Total revenues	$	231.4	$	222.1	$	9.3	$	8.9	$	0.4

Services revenues increased ~~18.0%~~4.3% to ~~$227.0~~$230.8 million for the three months ended ~~September 30, 2022~~March 31, 2023 from ~~$192.4~~$221.4 million for the three months ended ~~September 30, 2021. Services~~March 31, 2022. The increase in services revenues ~~delivered by base business resources increased by $18.2 million,~~is primarily ~~driven by increased demand for our services. Services~~attributable to services revenues delivered by resources of acquired companies, which increased ~~$16.5 million, resulting in a total net increase of $34.6~~$8.9 million.

Software and hardware revenues ~~increased 42.1%~~decreased to $0.6 million for the three months ended ~~September 30, 2022~~March 31, 2023 from ~~$0.4~~$0.7 million for the three months ended ~~September 30, 2021.~~March 31, 2022.

Cost of Revenues (exclusive of depreciation and amortization, discussed separately below). Cost of revenues increased ~~15.4%~~4.1% to ~~$136.4~~$144.2 million for the three months ended ~~September 30, 2022~~March 31, 2023 from ~~$118.3~~$138.5 million for the three months ended ~~September 30, 2021~~March 31, 2022 primarily due to higher headcount. Services costs as a percentage of services revenues decreased to ~~60.1%~~62.5% for the three months ended ~~September 30, 2022~~March 31, 2023 from ~~61.5%~~62.6% for the three months ended ~~September 30, 2021, primarily due to a continued shift to higher margin offshore and nearshore delivery.~~March 31, 2022.

Selling, General and Administrative. SG&A expenses increased to ~~$44.3~~$43.9 million for the three months ended ~~September 30, 2022~~March 31, 2023 from ~~$39.3~~$42.3 million for the three months ended ~~September 30, 2021.~~March 31, 2022. SG&A expenses as a percentage of revenues ~~decreased to 19.5%~~were 19.0% for each of the three months ended September 30, 2022 from 20.4% for the three months ended September 30, 2021, primarily due to a $2.4 million decrease in bonus expense for the three months ended September 30, 2022 compared to the three months ended September 30, 2021.March 31, 2023 and March 31, 2022.

Depreciation. Depreciation expense increased ~~46.5%~~23.1% to ~~$2.4~~$2.3 million for the three months ended ~~September 30, 2022~~March 31, 2023 from ~~$1.6~~$1.9 million for the three months ended ~~September 30, 2021.~~March 31, 2022. Depreciation expense as a percentage of revenues was 1.0% for the three months ended ~~September 30, 2022~~March 31, 2023 and 0.8% for the three months ended ~~September 30, 2021.~~March 31, 2022.

Amortization. Amortization expense ~~increased 41.0%~~decreased 2.7% to ~~$6.1~~$5.8 million for the three months ended ~~September 30, 2022~~March 31, 2023 from ~~$4.3~~$6.0 million for the three months ended ~~September 30, 2021.~~March 31, 2022. Amortization expense as a percentage of revenues was 2.5% for the three months ended March 31, 2023 and 2.7% for the three months ended September 30, 2022 and 2.2% for the three months ended September 30, 2021. The increase in amortization expense was primarily due to the addition of intangibles from the acquisition of substantially all of the assets of Talos LLC and Talos Digital LLC and all of the outstanding capital stock of Talos Digital SAS and TCOMM SAS (collectively, “Talos”) on September 8, 2021, the acquisition of Izmul S.A. (“Overactive”) on October 15, 2021, and the acquisition of Inflection Point Systems, Inc. (“Inflection Point”) on September 7,March 31, 2022.

Acquisition Costs. Acquisition-related costs were ~~$2.1~~$0.1 million for the three months ended ~~September 30, 2022~~March 31, 2023 and ~~$1.3~~$0.3 million for the three months ended ~~September 30, 2021.~~March 31, 2022. Costs were incurred for legal, accounting, tax, investment bank and advisor fees, and valuation services performed by third parties in connection with merger and acquisition-related activities.

Adjustment to Fair Value of Contingent Consideration. An adjustment of ~~$3.1~~$2.0 million was recorded during the three months ended ~~September 30, 2022~~March 31, 2023 which represents the net fair market value adjustment to ~~Talos and Overactive~~Inflection Point Systems, Inc. (“Inflection Point”) revenue and earnings-based contingent consideration liabilities, ~~in addition to accretion.~~net of accretion for Inflection Point and Ameex Technologies Corporation (“Ameex”). An ~~immaterial~~ adjustment of $1.0 million was recorded during the

three months ended ~~September 30, 2021~~March 31, 2022 which represents the net fair market ~~value~~ adjustment to the ~~Catalyst Networks Inc. (“Brainjocks”)~~ revenue and earnings-based contingent consideration liabilities for Talos LLC, Talos Digital LLC, Talos Digital SAS and TCOMM SAS (“Talos”), net of ~~accretion.~~accretion for Talos and Izmul S.A. (“Overactive”).

Net Interest Expense. Net interest expense decreased to ~~$0.6~~$0.5 million for the three months ended ~~September 30, 2022~~March 31, 2023 from ~~$3.5~~$0.9 million for the three months ended ~~September 30, 2021.~~March 31, 2022. The decrease in net interest expense was primarily due to ~~the adoption of Accounting Standards Update (“ASU”) 2020-06. Prior period amounts have not been adjusted due to the adoption of ASU 2020-06 under the modified retrospective method.~~a $0.3 million increase in interest income.

Provision for Income Taxes. Federal, state and foreign income taxes are provided for at the applicable statutory rates adjusted for non-deductible expenses. The effective tax rate increased to ~~29.4%~~26.6% for the three months ended ~~September 30, 2022~~March 31, 2023 from ~~28.1%~~17.9% for the three months ended ~~September 30, 2021.~~March 31, 2022. The increase in effective tax rate was primarily due to ~~the~~a relative decrease in ~~research credit benefit and increase in state tax expense partially offset by a decrease in expense related to a one-time statutory tax rate change in Colombia~~share-based compensation deductions compared to the prior year quarter.

~~Nine months ended September 30, 2022 compared to nine months ended September 30, 2021~~

~~Revenues.~~ ~~Total revenues increased 23.1% to $672.5 million for the nine months ended September 30, 2022 from $546.3 million for the nine months ended September 30, 2021.~~

Financial Results
(in thousands) Explanation for Increases Over Prior Year Period (in thousands)
Nine Months Ended September 30, Total Increase Over Prior Year Period Increase Attributable to Revenue Delivered by Resources of Acquired Companies Increase Attributable to Revenue Delivered by Base Business Resources
2022 2021
Services revenues $ 670,741 $ 544,924 $ 125,817 $ 47,901 $ 77,916
Software and hardware revenues 1,722 1,373 349 5 344
Total revenues $ 672,463 $ 546,297 $ 126,166 $ 47,906 $ 78,260

Services revenues increased 23.1% to $670.7 million for the nine months ended September 30, 2022 from $544.9 million for the nine months ended September 30, 2021. Services revenues delivered by base business resources increased by $77.9 million, primarily driven by increased demand for our services. Services revenues delivered by resources of acquired companies increased $47.9 million, resulting in a total net increase of $125.8 million.

~~Software and hardware revenues increased 25.4% to $1.7 million for the nine months ended September 30, 2022 from $1.4 million for the nine months ended September 30, 2021.~~

~~Cost of Revenues (exclusive of depreciation and amortization, discussed separately below).~~ Cost of revenues increased 22.0% to $411.7 million for the nine months ended September 30, 2022 from $337.5 million for the nine months ended September 30, 2021 primarily due to higher headcount. Services costs as a percentage of services revenues decreased to 61.4% for the nine months ended September 30, 2022 from 61.9% for the nine months ended September 30, 2021, primarily due to a continued shift to higher margin offshore and nearshore delivery.

~~Selling, General and Administrative.~~ SG&A expenses increased to $127.4 million for the nine months ended September 30, 2022 from $110.7 million for the nine months ended September 30, 2021. SG&A expenses as a percentage of revenues decreased to 18.9% for the nine months ended September 30, 2022 from 20.3% for the nine months ended September 30, 2021, primarily due to a $6.1 million decrease in bonus expense for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021.

~~Depreciation~~. Depreciation expense increased 33.1% to $6.2 million for the nine months ended September 30, 2022 from $4.7 million for the nine months ended September 30, 2021. Depreciation expense as a percentage of revenues was 0.9% for the nine months ended September 30, 2022 and 2021.

~~Amortization.~~ Amortization expense increased 2.0% to $18.1 million for the nine months ended September 30, 2022 from $17.7 million for the nine months ended September 30, 2021. Amortization expense as a percentage of revenues was 2.7% for the nine months ended September 30, 2022 and 3.2% for the nine months ended September 30, 2021. The increase in

amortization expense was primarily due to the addition of intangibles from the acquisition of Talos on September 8, 2021, the acquisition of Overactive on October 15, 2021, and the acquisition of Inflection Point on September 7, 2022.

~~Acquisition Costs.~~ Acquisition-related costs were $2.5 million and $1.3 million for the nine months ended September 30, 2022 and 2021, respectively. Costs were incurred for legal, accounting, tax, investment bank and advisor fees, and valuation services performed by third parties in connection with merger and acquisition-related activities.

~~Adjustment to Fair Value of Contingent Consideration~~. An adjustment of $0.4 million was recorded during the nine months ended September 30, 2022 which represents the net fair market value adjustment to the Talos and Overactive revenue and earnings-based contingent consideration liabilities, net of accretion. An immaterial adjustment was recorded during the nine months ended September 30, 2021 which represents the net impact of the fair market value adjustment to the Productora de Software S.A.S. (“PSL”~~), Brainjocks, and MedTouch LLC (“Medtouch~~”~~) revenue and earnings-based consideration liabilities, in addition to accretion.~~

~~Net Interest Expense.~~ Net interest expense decreased to $2.3 million for the nine months ended September 30, 2022 from $10.1 million for the nine months ended September 30, 2021. The decrease in net interest expense was primarily due to the adoption of ASU 2020-06. Prior period amounts have not been adjusted due to the adoption of ASU 2020-06 under the modified retrospective method.

~~Provision for Income Taxes.~~ Federal, state and foreign income taxes are provided for at the applicable statutory rates adjusted for non-deductible expenses. The effective tax rate decreased to 25.2% for the nine months ended September 30, 2022 from 25.3% for the nine months ended September 30, 2021. The decrease in effective tax rate was primarily due to the decrease in expense related to a one-time statutory tax rate change in Colombia partially offset by a relative decrease in research credit benefit compared to the prior year period.

Liquidity and Capital Resources

Selected measures of liquidity and capital resources are as follows (in millions):


		September 30, 2022		December 31, 2021			March 31, 2023		December 31, 2022
Cash and cash equivalents (1)	Cash and cash equivalents (1)	$	20.8	$	24.4	Cash and cash equivalents (1)	$	41.0	$	30.1
Working capital (including cash and cash equivalents) (2)	Working capital (including cash and cash equivalents) (2)	$	121.0	$	94.8	Working capital (including cash and cash equivalents) (2)	158.7		126.5
Amounts available under credit facility	Amounts available under credit facility	$	199.8	$	199.8	Amounts available under credit facility	$	299.8	$	199.8

(1) The balance at ~~September 30, 2022~~March 31, 2023 includes ~~$9.2~~$9.7 million held by certain foreign subsidiaries which is not available to fund domestic operations unless deemed repatriated. We currently do not plan or foresee a need to repatriate such funds. The balance also includes ~~$6.5~~$7.5 million in cash held by certain other foreign subsidiaries which is available to fund domestic operations. The

balance at December 31, ~~2021~~2022 includes ~~$6.1~~$7.9 million held by certain foreign subsidiaries which is not available to fund domestic operations unless deemed repatriated. The balance also includes ~~$5.2~~$7.8 million in cash held by certain other foreign subsidiaries which is available to fund domestic operations.

(2) Working capital is total current assets less total current liabilities.

Net Cash Provided by Operating Activities

Net cash provided by operating activities for the ~~nine~~three months ended ~~September 30, 2022~~March 31, 2023 was ~~$71.4~~$41.3 million compared to net cash provided by operating activities of ~~$38.1~~$11.2 million for the ~~nine~~three months ended ~~September 30, 2021.~~March 31, 2022. For the ~~nine~~three months ended ~~September 30,~~March 31, 2023, the primary components of operating cash flows were net income of $26.8 million, non-cash charges of $11.5 million and net operating asset reductions of $3.0 million. For the three months ended March 31, 2022, the primary components of operating cash flows were net income of ~~$77.9~~$27.1 million, non-cash charges of ~~$36.1~~$17.3 million and net operating asset investments of $42.6 million. For the nine months ended September 30, 2021, the primary components of operating cash flows were net income of $47.6 million, non-cash charges of $45.1 million and net operating asset investments of $54.6$33.2 million.

Net Cash Used in Investing Activities

During the ~~nine~~three months ended ~~September 30, 2022,~~March 31, 2023, we used ~~$7.7~~$1.3 million to purchase property and equipment and to develop ~~software, $44.6~~software. During the three months ended March 31, 2022, we used $2.6 million ~~for the acquisition of Inflection Point,~~to purchase property and equipment and to develop software and $0.1 million for a net working capital settlement related to an acquisition. ~~During the nine months ended September 30, 2021, we used $14.9 million for the acquisition of Talos and $6.7 million to purchase property and equipment and to develop software.~~

Net Cash Used in Financing Activities

During the ~~nine~~three months ended ~~September 30, 2022,~~March 31, 2023, we used ~~$13.0~~$2.4 million to repurchase shares of our common stock through the stock repurchase program and $5.1 million to remit taxes withheld as part of a net share settlement of restricted stock vesting. We also used $0.7 million for credit facility financing fees, used $21.5 million to settle contingent consideration for the purchase of Talos and Overactive and received proceeds from sales of stock through the Employee Stock Purchase Plan of $0.2 million. During the three months ended March 31, 2022, we used $9.0 million to remit taxes withheld as part of a net share settlement of restricted stock vesting. We also ~~drew down $10.0 million from our line of credit, repaid $10.0 million million on our line of credit and~~ received proceeds from sales of stock through the Employee Stock Purchase Plan of $0.8 million. During the nine months ended September 30, 2021, we used $17.9 million to repurchase shares of our common stock through the stock repurchase program, $13.9 million to repurchase the remainder of the 2.375% Convertible Senior Notes due 2023 (the “2023 Notes”), received $6.1 million related to the sale of privately negotiated convertible hedge transactions of the 2023 Notes, and paid $5.0 million for the repurchase of net-share-settled warrants related to the 2023 Notes. We used $6.5 million to settle contingent consideration for the purchase of MedTouch and Brainjocks, $5.2 million to remit taxes withheld as part of a net share settlement of restricted stock vesting, and $0.6 million to amend the 2021 Credit Agreement. We also received proceeds from sales of stock through the Employee Stock Purchase Plan of $0.4$0.3 million.

Availability of Funds from Bank Line of Credit Facility

On ~~May 7, 2021,~~March 29, 2023, the Company ~~entered~~amended and restated its existing credit agreement by entering into ana Second Amended and Restated Credit Agreement (the ~~“2021~~“2023 Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent and the other lenders parties thereto. The ~~2021~~2023 Credit Agreement provides for revolving credit borrowings up to a maximum principal amount of ~~$200.0~~$300.0 million, subject to a commitment increase of $75.0 million. All outstanding amounts owed under the ~~2021~~2023 Credit Agreement become due and payable no later than the final maturity date of ~~May 7, 2026.~~March 29, 2028. As of ~~September 30, 2022,~~March 31, 2023, there was no outstanding balance under the ~~2021~~2023 Credit Agreement. The Company incurred ~~$0.6~~$0.8 million of ~~deferred finance fees as a result of the 2021 Credit Agreement during the nine months ended September 30, 2021. The Company did not incur any~~ additional deferred finance fees during the three ~~and nine~~ months ended ~~September 30, 2022.~~March 31, 2023.

At ~~September 30, 2022,~~March 31, 2023, the Company was in compliance with all covenants under the ~~2021~~2023 Credit Agreement.

Stock Repurchase Program

management based on its evaluation of market conditions, share price, and other factors. Since the program’s inception on August 11, 2008, the Company has repurchased approximately ~~$274.4~~$282.2 million ~~(16.3~~(16.4 million shares) of outstanding common stock through ~~September 30, 2022.~~March 31, 2023.

From time to time, the Company establishes a written trading plan in accordance with Rule 10b5-1 of the Exchange Act, pursuant to which the Company makes a portion of its stock repurchases. Additional repurchases will be at times and in amounts as the Company deems appropriate and will be made through open market transactions in compliance with Rule 10b-18 of the Exchange Act, subject to market conditions, applicable legal requirements, and other factors.

Cash Requirements from Contractual Obligations

For the ~~nine~~three months ended ~~September 30, 2022,~~March 31, 2023, there were no material changes outside the ordinary course of business in lease obligations or contractual obligations. See Note 15, Leases, in the Notes to Interim Condensed Consolidated Financial Statements for further description of our contractual obligations.

As of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021,~~2022, there were no balances outstanding under the ~~2021~~2023 Credit Agreement. Any balances outstanding under the ~~2021~~2023 Credit Agreement would be classified as “Long-term debt” within the Condensed Consolidated Balance Sheet and become due and payable no later than the final maturity date of ~~May 7, 2026.~~March 29, 2028. As of ~~September 30, 2022,~~March 31, 2023, there were ~~$394.1~~$395.2 million of outstanding 2026 Notes and 2025 Notes, net of unamortized issuance costs, compared to ~~$326.1~~$394.6 million as of December 31, ~~2021.~~2022. See Note 3, Recent Accounting Pronouncements, in the Notes to Interim Unaudited Condensed Consolidated Financial Statements for further description of the ASU 2020-06 adoption. ~~As of December 31, 2021, the 2023 Notes were fully repurchased.~~ The amounts are classified as “Long-term debt” within the Condensed Consolidated Balance Sheets as of ~~September 30, 2022~~March 31, 2023 (unaudited) and December 31, ~~2021.~~2022. The 2026 Notes will become due and payable no later than the final maturity date of November 15, 2026. The 2025 Notes will become due and payable no later than the final maturity date of August 1, 2025.

Conclusion

Of the total cash and cash equivalents reported on the Condensed Consolidated Balance Sheet as of ~~September 30, 2022~~March 31, 2023 (unaudited) of ~~$20.8~~$41.0 million, approximately ~~$9.2~~$9.7 million was held by certain foreign subsidiaries and is considered to be indefinitely reinvested in those operations. The Company is able to fund its liquidity needs outside of these subsidiaries, primarily through cash flows generated by domestic operations and our credit ~~facility, as well as the proceeds from the 2026 Notes issuances in the fourth quarter of 2021.~~facility. Therefore, the Company has no current plans to repatriate cash from these foreign subsidiaries in the foreseeable future. As of ~~September 30, 2022, $6.5~~March 31, 2023, $7.5 million of the total cash and cash equivalents was held by certain other foreign subsidiaries where the Company has determined that the earnings from these subsidiaries are not permanently reinvested and may repatriate available earnings from these subsidiaries from time to time.

We believe that the currently available funds, access to capital from our credit facility, and cash flows generated from operations will be sufficient to meet our working capital requirements and other capital needs for the next 12 months. However, while the Company did not experience a material impact on the business, operations or financial results from ~~the COVID-19 pandemic~~health emergencies and pandemics during the ~~nine~~three months ended ~~September 30, 2022,~~March 31, 2023, the pandemic may materially and adversely affect our business, operations and financial results, including our cash flows, in the future. See “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 for additional information regarding the potential impact of ~~COVID-19~~health emergencies and pandemics on the Company.

Critical Accounting Policies

Our accounting policies are fully described in Note 2, Summary of Significant Accounting Policies, to our Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, ~~2021.~~2022. We believe our most critical accounting policies include revenue recognition, purchase accounting and related fair value measurements, convertible debt, and income taxes. Refer to Note 3, Recent Accounting Pronouncements, in the Notes to Interim Unaudited Condensed Consolidated Financial Statements for further discussion regarding the adoption of ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) on January 1, 2022.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are exposed to market risks related to changes in foreign currency exchange rates and interest rates. We believe our exposure to market risks is immaterial.

Exchange Rate Sensitivity

We are exposed to market risks associated with changes in foreign currency exchange rates because we generate a portion of our revenues and incur a portion of our expenses in currencies other than the U.S. dollar. As of ~~September 30, 2022,~~March 31, 2023, we were exposed to changes in exchange rates between the U.S. dollar and eleven other currencies. We hedge material foreign currency exchange rate exposures when feasible using forward contracts. These instruments are subject to fluctuations in foreign currency exchange rates and credit risk. Credit risk is managed through careful selection and ongoing evaluation of the financial institutions utilized as counterparties. Refer to Note 13, Derivatives, in the Notes to Interim Unaudited Condensed Consolidated Financial Statements for further discussion.

Interest Rate Sensitivity

As of ~~September 30, 2022,~~March 31, 2023, there was no outstanding balance and ~~$199.8~~$299.8 million of available borrowing capacity under our credit facility. To the extent we have outstanding borrowings under the credit facility, our interest expense will fluctuate as

the interest rate for the line of credit floats based, at our option, on the prime rate plus a margin or the one-month ~~LIBOR~~SOFR rate plus a margin.

During the third quarter of 2020 and the fourth quarter of 2021, we issued the 2025 Notes and the 2026 Notes, respectively, which have a fixed interest rate of 1.250% and 0.125%, respectively. The fair value of the Notes may increase or decrease for various reasons, including fluctuations in the market price of our common stock, fluctuations in market interest rates and fluctuations in general economic conditions. Based upon the quoted market price as of ~~September 30, 2022,~~March 31, 2023, the fair value of the 2025 Notes and 2026 Notes was approximately ~~$31.8~~$34.7 million and ~~$284.2~~$305.9 million, respectively.

We had unrestricted cash and cash equivalents totaling ~~$20.8~~$41.0 million at ~~September 30, 2022~~March 31, 2023 and ~~$24.4~~$30.1 million at December 31, ~~2021.~~2022. The unrestricted cash and cash equivalents are primarily held for working capital purposes and acquisitions. We do not enter into investments for trading or speculative purposes.

Item 4. Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s reports under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the principal executive officer and principal financial officer of the Company, as appropriate, to allow timely decisions regarding required disclosure. The Company’s management, with the participation of the Company’s principal executive officer and principal financial officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Form 10-Q. Based on that evaluation, the Company’s principal executive and principal financial officers have determined that the Company’s disclosure controls and procedures were effective.

There were no significant changes in the Company’s internal control over financial reporting as defined in Exchange Act Rule 13a-15(f) during the three months ended ~~September 30, 2022,~~March 31, 2023, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. ~~The Company’s remote work in response to the COVID-19 pandemic has not resulted in a material impact to the Company’s internal controls over financial reporting.~~

PART II. OTHER INFORMATION

Item 1A. Risk Factors

In evaluating all forward-looking statements, you should specifically consider various risk factors that may cause actual results to vary from those contained in the forward-looking statements. Our risk factors are described in our Annual Report on Form 10-K for the year ended December 31, ~~2021,~~2022, as filed with the SEC on February ~~24, 2022~~28, 2023 and available at www.sec.gov.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

~~Unregistered Sale of Securities~~

On September 7, 2022, the Company acquired all of the outstanding stock of Inflection Point. The consideration paid in this transaction included 49,439 unregistered shares of the Company’s common stock with an aggregate value of approximately $4.3 million based on the average closing sales price for the 30 consecutive trading days ending on the date immediately before the acquisition's closing date.

The Company relied on Section 4(a)(2) of the Securities Act of 1933, as amended, as the basis for exemption from registration for this issuance. These shares were issued in a privately negotiated transaction and not pursuant to a public solicitation.

~~Issuer Purchases of Securities~~

Stock Repurchase Program

program could be suspended or discontinued at any time based on market, economic, or business conditions. The timing and amount of repurchase transactions will be determined by management based on its evaluation of market conditions, share price, and other factors.

From the program’s inception on August 11, 2008, the Company has repurchased approximately ~~$274.4~~$282.2 million ~~(16.3~~(16.4 million shares) of outstanding common stock through ~~September 30, 2022.~~March 31, 2023.

Period Total Number of
Shares Purchased Average Price
Paid Per Share (1) Total Number of Shares
Purchased as Part of Publicly
Announced Plans or Programs Approximate Dollar Value
of Shares that May Yet
Be Purchased Under
the Plans or Programs
Beginning balance as of June 30, 2022 16,152,294 $ 16.42 16,152,294 $ 49,849,516
July 1-31, 2022 — $ — — $ 49,849,516
August 1-31, 2022 103,000 $ 83.96 103,000 $ 41,201,928
September 1-30, 2022 8,000 $ 73.33 8,000 $ 40,615,295
Ending balance as of September 30, 2022 16,263,294 $ 16.87 16,263,294


Period	Total Number of Shares Purchased	Average Price Paid Per Share (1)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in millions)
Beginning balance as of December 31, 2022	16,343,294	$	17.12	16,343,294	$	95.2
January 1-31, 2023	—	$	—	—	$	95.2
February 1-28, 2023	—	$	—	—	$	95.2
March 1-31, 2023	35,000	$	68.41	35,000	$	92.8
Ending balance as of March 31, 2023	16,378,294	$	17.23	16,378,294

(1)Average price paid per share includes commission.

Item 5. Other Information

None.

Item 6. Exhibits

See Exhibits Index.

3829

EXHIBITS INDEX


Exhibit Number			Description
3.1			Certificate of Incorporation of Perficient, Inc., previously filed with the Securities and Exchange Commission as an Exhibit to our Registration Statement on Form SB-2 (File No. 333-78337) declared effective on July 28, 1999 by the Securities and Exchange Commission and incorporated herein by reference
3.2			Certificate of Amendment to Certificate of Incorporation of Perficient, Inc., previously filed with the Securities and Exchange Commission as an Exhibit to our Form 8-A (File No. 000-51167) filed with the Securities and Exchange Commission pursuant to Section 12(g) of the Securities Exchange Act of 1934 on February 15, 2005 and incorporated herein by reference
3.3			Certificate of Amendment to Certificate of Incorporation of Perficient, Inc., previously filed with the Securities and Exchange Commission as an Exhibit to our Registration Statement on Form S-8 (File No. 333-130624) filed on December 22, 2005 and incorporated herein by reference
3.4			Certificate of Amendment to Certificate of Incorporation of Perficient, Inc., previously filed with the Securities and Exchange Commission as an Exhibit to our Quarterly Report on Form 10-Q (File No. 001-15169) filed August 3, 2017 and incorporated herein by reference
3.5			Amended and Restated Bylaws of Perficient, Inc., previously filed with the Securities and Exchange Commission as an Exhibit to our Annual Report on Form 10-K for the year ended December 31, 2012 (File No. 001-15169) filed March 7, 2013 and incorporated herein by reference
4.1			Specimen Certificate for shares of Perficient, Inc. common stock, previously filed with the Securities and Exchange Commission as an Exhibit to our Quarterly Report on Form 10-Q (File No. 001-15169) filed May 7, 2009 and incorporated herein by reference
4.2			Indenture, dated August 14, 2020, between Perficient, Inc. and U.S. Bank National Association, as trustee, relating to the Company’s 1.250% Convertible Senior Notes due 2025, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K (File No. 001-15169) filed August 18, 2020 and incorporated herein by reference
4.3			Form of 1.250% Convertible Senior Notes due 2025, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K filed August 18, 2020 and incorporated herein by reference
4.4			Indenture, dated November 9, 2021, between Perficient, Inc. and U.S. Bank National Associate, as trustee, relating to the Company's 0.125% Convertible Senior Notes due 2026, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K filed November 9, 2021 and incorporated herein by reference
4.5			Form of 0.125% Convertible Senior Notes due 2026, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K filed November 9, 2021 and incorporated herein by reference
10.1*			Second Amended and Restated Credit Agreement, dated as of March 29, 2023, by and among Perficient, Inc., as Borrower, Wells Fargo Bank, National Association, as administrative agent, swingline lender and issuing lender, Bank of America, N.A. and U.S. Bank National Association, as syndication agents, JPMorgan Chase Bank, N.A., as documentation agent, Wells Fargo Securities, LLC, BofA Securities, Inc. and U.S. Bank National Association as joint lead arrangers and joint bookrunners and the other lenders parties thereto.
31.1*			Certification by the Chief Executive Officer of Perficient, Inc. as required by Section 302 of the Sarbanes-Oxley Act of 2002
31.2*			Certification by the Chief Financial Officer of Perficient, Inc. as required by Section 302 of the Sarbanes-Oxley Act of 2002
32.1**			Certification by the Chief Executive Officer and Chief Financial Officer of Perficient, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101*			The following financial information from Perficient, Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended ~~September 30, 2022~~March 31, 2023 formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of ~~September 30, 2022~~March 31, 2023 (Unaudited) and December 31, ~~2021,~~2022, (ii) Unaudited Condensed Consolidated Statements of Operations for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ (iii) Unaudited Condensed Consolidated Statements of Comprehensive Income for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ (iv) Unaudited Condensed Consolidated Statements of Shareholders’ Equity for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ (v) Unaudited Condensed Consolidated Statements of Cash Flows for the ~~nine~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ and (vi) the Notes to Interim Unaudited Condensed Consolidated Financial Statements
104			Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101)

†			Identifies an Exhibit that consists of or includes a management contract or compensatory plan or arrangement.


*			Filed herewith.
**			Included but not to be considered “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		PERFICIENT, INC.

Date:	~~October 27, 2022~~May 2, 2023	By:	/s/ Jeffrey S. Davis
			Jeffrey S. Davis
			Chief Executive Officer (Principal Executive Officer)


Date:	~~October 27, 2022~~May 2, 2023	By:	/s/ Paul E. Martin
			Paul E. Martin
			Chief Financial Officer (Principal Financial Officer)

4031


Other non-current liabilities:
Deferred income taxes	$	8,051	$	13,075
Reserve for uncertain tax positions	20,951		19,127
Deferred compensation liability	8,363		9,458
Other non-current liabilities	6,155		3,462
Non-current software accrual	2,221		2,710
Total	$	45,741	$	47,832


	Talos			Overactive
Cash, net of cash acquired	$	14.9		$	93.9
Company common stock issued at closing	3.8			2.4
Contingent consideration (1)	9.0		(2)	12.6		(3)
Net working capital adjustment due to the seller(s)	0.1			1.4
Total allocable purchase price consideration	$	27.8		$	110.3